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The multi-gene family stevor in Plasmodium falciparum is thought to play a 
role in antigenic variation and virulence. Although transcriptional regulation in the 
related var multi-gene family has been shown to be mediated, in part, by promoter 
activity within its intron, the possible role of the stevor intron or the var intron in 
stevor‟s transcriptional regulation is not known. Transient transfection experiments 
using renilla and firefly luciferase reporter genes were performed to investigate the 
transcriptional regulation of stevor using constructs that shared a stevor gene with or 
without a downstream var intron. Unsuccessful transfections provided the basis for 
modifying the approach: constructs that had a lengthened upstream region from the 
stevor gene start site, with the intent of covering the complete promoter region of 
stevor, were cloned and used for subsequent transient transfections. Successful 
transfections were accomplished, and preliminary results based on one transfection 
suggest that the promoter of stevor is not affected by the var intron. Further 
experiments are required to confirm this finding. Due to limiting information about 
stevor transcriptional regulation, the determination of one basic characteristic of this 
multi-gene family was attempted, namely the lengths of the 5‟UTRs of this multi-gene 
family. Unfortunately, this was not able to be determined; however, with a few 
modifications in the protocol future experiments will allow the elucidation of the 
lengths of these 5‟UTRs. Repeating these transfections and following the suggested 
modifications in the protocol of the 5‟UTRs experiments will allow us to come one 
step closer to understanding the transcriptional regulation of this important multi-gene 




List of Figures 
Figure 1.1 Worldwide distribution of P. falciparum 3 
Figure 1.2  Structure of rif_A and rif_B and stevor  16 
Figure 1.3 Models of membrane topologies for STEVOR proteins  17 
Figure 1.4  
Overview of predominant transcription time points of the 
var, stevor, and rif multi-gene families during the blood stage 
of P. falciparum 
17 
Figure 1.5 
Summary of Dzikowski and colleagues experiment supporting the 
var silencing intron-mediated repression hypothesis  
21 
Figure 2.1  
Stevor gene fragment sequences of the constructs used for 
transfections 
31 
Figure 2.2  




Stevor constructs that had their firefly luciferase gene replaced 
with the renilla luciferase gene for the use in transfection 
experiments into 3D7 
33 
Figure 2.4  New stevor gene constructs PF10_0395 34 
Figure 3.1 Construct pARL-RL (A) and pARL-FL (B) 42 
Figure 3.2  
The constructs pARL-5‟-3‟-UTR-actin renilla luciferase (A) and 
pARL-5‟-3‟-UTR-actin firefly luciferase (B) 
43 
Figure 3.3 
Transfection with 100 µg of pARL-5‟-3‟-UTR-actin-renilla 
luciferase construct 
44 
Figure 3.4  
Transfection with 100 µg of pARL-5‟-3‟-UTR-actin-firefly 
luciferase construct 
44 
Figure 3.5   
Example of a schizont extract after passing the parasite culture 
through a CS SuperMACS column 
45 
Figure 3.6  
Transfection of 50 µg of pARL-5‟-3‟-UTR-actin-firefly luciferase 
together with 50 µg of pARL-5‟-3‟-UTR-actin-renilla luciferase, 
100µg pPf86 positive control construct and 100 µl of  10% TE in 




Figure 3.7  
Stevor constructs pSt-I (A), pSt-I var (B), pSt-I-R (C) and pSt-I-R 
var (D), they all have the same pARL backbone 
48 
Figure 3.8  
Newly made negative control constructs Negative control RL (A) 
and Negative control FL (B) 
50 
Figure 3.9  
Transfection with the stevor gene PFB1020w of P. falciparum 
3D7, with and without a downstream var intron: pSt-I and pSt-I 
var intron, respectively 
51 
Figure 3.10 
Average firefly/renilla ratios of 50:50, 75:25, 87.5:12.5 of both 
pSt-I/pARL-5‟-3‟-UTR-actin renilla luciferase and pSt-I var 
intron/pARL-5‟-3‟-UTR-actin renilla luciferase, respectively 
52 
Figure 3.11  
Repeat of the transfection with the stevor gene PFB1020w of P. 
falciparum 3D7, with and without a downstream var intron: pSt-I 
and pSt-I var intron, respectively 
53 
Figure 3.12 
Average firefly/renilla ratios of 50:50, 75:25, 87.5:12.5 of both 
pSt-I/pARL-5-‟3‟-UTR-actin renilla luciferase and pSt-I var 
intron/pARL-5‟-3‟-UTR-actin renilla luciferase, respectively, 
from repeat experiment 
54 
Figure 3.13  
Restriction enzyme digestion of Negative control firefly 
luciferase (FL) plasmids extracted from five positive colonies 
with Avr II and Bgl II 
55 
Figure 3.14 
Restriction enzyme digestion of Negative control renilla 
luciferase (RL) plasmids extracted from five positive colonies 
with Avr II and Bgl II 
55 
Figure 3.15  
Transfection with 100 µg of pSt-I and 100 µg of pVlh, in 
duplicate, single pPf86 positive control (LU = 14 094) 
56 
Figure 3.16 
pSt-I-RL and pSt-I-var-RL positive colony purified plasmid 
constructs 
57 
Figure 3.17  
Positive colonies that resulted from the cloning of PF10_0395 
stevor gene and its upstream region 
58 
Figure 3.18 
Constructs PF10_0395 NI FL and PF10_0395 NI FLV (both 
share the same backbone of pARL) 
59 
Figure 3.19  
Troubleshooting of transient transfection experiments: ruling out 
cytomix and positive control pPf86 construct 
60 
Figure 3.20 Transfection of PF10_0395 NI FL and PF10_0395 NI FLV 61 
Figure 3.21  
Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-5‟-
3‟UTR renilla luciferase, PF10_0395 NI FL/pARL-5‟-3‟UTR 
renilla luciferase, positive control pPf86/ pARL-5‟3‟UTR renilla 
luciferase and pARL-FL negative control/pARL-RL negative 









Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-
5‟3‟UTR renilla luciferase, PF10_0395 NI FL/pARL-5‟-3‟UTR 
renilla luciferase, positive control pPf86/ pARL-5‟-3‟UTR renilla 
luciferase and pARL-FL negative control/pARL-RL negative 
control, data from Figure 3.22 
62 
Figure 3.24 




Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-5‟-
3‟UTR renilla luciferase, PF10_0395 NI FL/pARL-5‟-3‟UTR 
renilla luciferase, positive control pPf86/ pARL-5‟-3‟UTR renilla 
luciferase and pARL-FL negative control/pARL-RL negative 
control, data from Figure 3.24 
65 
Figure 3.26 
Attempted repetition of re-invasion transfection PF10_0395 NI 
FL and PF10_0395 NI FLV 
66 
Figure 3.27 
Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-
5‟3‟UTR renilla luciferase, PF10_0395 NI FL/pARL-5‟3‟UTR 
renilla luciferase, positive control pPf86/ pARL-5‟3‟UTR renilla 
luciferase and pARL-FL negative control/pARL-RL negative 
control, data from Figure 3.26 
66 
Figure 3.28 
Control for primers GSP2 and GSP3 used for the dc-tailed cDNA 
PCR and nested PCR 
68 
Figure 3.29 




List of Tables 
 
Table 2.1 Components of P. falciparum media 26 
Table 2.2  Constructs used for transient transfection 32 
Table 2.3  
Primers used for successful cloning of PF10_0395 NI FL, 
PF10_0395 NI FL V, and the two negative control constructs 
35 
Table 2.4  
PCR reaction conditions used for genomic 3D7 DNA and 
plasmid DNA 
35 
Table 2.5  
Touchdown PCR reaction conditions used for genomic 3D7 




Primers used for the determination of 5‟UTRs of three stevor 





Rationale and result summary of each construct used in 
transient transfection experiments with P. falciparum. Self-






Electroporation time constant (TC), voltage, Firefly LUs and 
Renilla LUs for each transfection using PF10_0395 NI FL and 
PF10_0395 NI FL V constructs 
86 





2TM   Two trans-membrane 
 
CIDR   Cysteine-rich inter-domain regions 
 
cRPMI   complete RPMI medium 
 
DBL   Duffy-like binding  
 
EB   Elution buffer 
 
FL   Firefly luciferase  
 
gDNA   genomic DNA 
 
HEPES  hydroxyethylpiperazineethanesulfonic acids 
 
iRPMI   incomplete RPMI 
 
iER(s)   infected erythrocytes 
 
kb   kilo bases 
 
kDa   kilo Daltons 
 
LU   Luminescence unit 
 
MACS   Magnetic activated cell sorting 
 
MC   Maurer‟s cleft 
 
min   minutes 
 
NI   No intron 
 
PBS   Phosphate buffer saline 
 
PCR   Polymerase chain reaction 
 
PfEMP1  Plasmodium falciparum erythrocyte membrane protein 1 
 
EGTA   Ethylene glycol tetraacetic acid  
 
ERs    Erythrocytes 
 




rif /RIFIN  repetitive interspersed family 
 
RL   Renilla luciferase 
 
RPMI   Roswell Park Memorial Institute 1640 medium 
 
sec   second 
 
STEVOR  Subtelomeric variable open reading frame 
 
USS   Upstream sequence 
 
UTR   Un-translated region 
 
TAE    Tris-acetate buffer containing ethylenediaminetetraacetic acid 
 
TdT   Terminal deoxynucleotidly transferase tailing 
 
TE   Tris-chloride buffer containing ethylenediaminetetraacetic acid 
 
var   variant antigens 
 














































Chapter 1: Introduction 
 
1.1 Malaria overview  
 
1.1.1 Impact of malaria 
 
For millennia malaria has been one of the most serious infectious diseases to 
affect humans, with children being the most vulnerable to its dangers. It is localized 
mainly in poor tropical and subtropical countries of the world. Its social and economic 
impact on these developing countries is enormous, with a strong correlation between 
the presence of malaria and poverty. As well, there are higher costs in lost economic 
growth in malaria-endemic areas (Sachs and Malaney, 2002).  
1.1.2 Epidemiology 
More than 300 to 500 million individuals are infected worldwide with 
Plasmodium spp. each year, with 2.2 billion at risk of infection and more than one 
million deaths occurring annually from the infection (Snow et al. 2005, Greenwood 
2005). Most of the deaths are in young children and pregnant women living in sub-
Saharan Africa. Malaria is endemic in over 90 countries and thirty-five of these 
countries (30 in Africa, 5 in Asia) account for 98% of all global malaria deaths (WHO 
2009). The two species P. vivax and P. falciparum cause over 95% of infections. 
Malaria transmission occurs mainly in tropical and sub-tropical regions of the world, 
as it is for the most part confined by a 16°C minimum temperature line, as parasite 
development ceases below this temperature. Humidity is also an important factor for 
malaria transmission, Figure 1.1 shows the worldwide malaria distribution based on 







Figure 1.1 Worldwide distribution of P. falciparum  
Populations at risk based on annual parasite incidence, aridity and temperature. Red: Areas defined as 
stable malaria, annual parasite incidence >0.1 per thousand pa, Pink: Unstable areas, annual parasite 
incidence <0.1 per thousand pa, Grey: no risk (Adapted from Guerra et al. 2008) 
 
1.1.3 History of malaria 
Malaria has been associated with humans for thousands of years. Written 
accounts of the disease have survived from many ancient civilizations; the Ebers 
Papyrus, circa 1570 BC from Egypt, documents symptoms of the disease, including 
the enlargement of the spleen and the accompaniment of fever. For centuries it was 
thought that malaria arose from miasmas, or, as the etymology of the word suggests, 
“bad air” found above marshy areas. However, in 1880 Alphonse Laveran discovered 
that a parasite was the causative agent for malaria, and thus detailed studies on these 
organisms began, including the discovery in 1897 by Ronald Ross in India that 
malaria was transmitted to humans by mosquitoes (Garcia 2010, Buonsensa and 
Cataldi 2010). Interestingly, recent evidence suggests that the origins of human 





1.1.4 The parasite and its vector 
Malaria is a protozoal disease. It is caused by the unicellular, obligate 
intracellular parasite of the genus Plasmodium. Plasmodium spp. are in the phylum 
Apicomplexa. There are five species of Plasmodium that infect humans: Plasmodium 
falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale and P. 
knowlesi, a simian malaria species that is emerging as an important zoonotic human 
pathogen. P. falciparum is the most prevalent and lethal of these malaria parasites. Its 
high virulence is due to its ability to invade all ages of blood cells with high 
efficiency, resulting in high parasitemia levels; the proportion of infected red blood 
cells may exceed 50%. Another reason is its unique ability to sequester and both of 
these factors are associated with the development of severe malaria (Kyes et al. 2001, 
Garcia 2010). P. vivax is the most widespread; especially in South and Southeast Asia 
and accounts for 70% of malaria cases in the Americas. It can re-occur several years 
after initial infection, although in most cases it produces less severe symptoms than P. 
falciparum, its chronic disease is debilitating (Mueller et al. 2009). P. ovale is rare; it 
too can cause relapses of up to four years from initial infection and is predominantly 
found in sub-Saharan Africa and some South Pacific islands (Collins and Jeffery 
2005, Garcia 2010). P. vivax and P. ovale both have a stage in their life cycle that the 
other three Plasmodium species lack; namely after the sporozoites invade the liver 
hepatocytes they can either develop into actively dividing schizonts or become 
dormant hynozoites. The determinant that dictates which developmental pathway the 
sporozoite takes is not known. Hynozoites can remain dormant for days, weeks or 
even years up until a trigger for activation occurs resulting in a blood infection and the 
development of clinical malaria (Mueller et al. 2009). P. malariae can persist in the 
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blood for very long periods without ever producing symptoms; it is predominantly 
found in sub-Saharan Africa with a strong overlap with P. falciparum‟s distribution 
(Collins and Jeffery 2007). P. knowlesi, the simian malaria parasite, is often 
misdiagnosed as P. malariae, however infections with this parasite species can be 
fatal. Increasingly, human infections with this parasite have been reported from 
forested regions of Southeast Asia, particularly in Malaysian-Borneo (Baird 2009).  
Anopheles spp. is the only mosquito genus, of which only the females, can act 
as vectors for malaria transmission. There are around 462 species but only about 70 
have been shown to be vectors for transmission. Anopheles gambiae is the most well-
known, as it is the predominant species in the transmission of P. falciparum. The 
distribution of Anopheles spp. is worldwide, and mainly in tropical and subtropical 
areas (Hay et al. 2010).  
Malaria is transmitted to humans following the bite of an infected female 
Anopheles spp. mosquito, whereby sporozoites located in the salivary glands of the 
mosquito are injected into human tissue. Within minutes the sporozoites reach the 
liver and invade hepatocytes, where the parasite matures, differentiates, and undergoes 
several rounds of asexual division, resulting in many thousands of infective haploid 
merozoites. There are no clinical symptoms during this period, and it is known as the 
pre-patent period. After 8-12 days merozoites are released into the bloodstream where 
the next stage of the parasite‟s life cycle begins: the blood stage and it is also when the 
symptomatic stage of the disease begins. Within seconds these newly released 
merozoites invade erythrocytes, forming ring-like structures for up to 26 hours post-
invasion. Thereafter they enter the trophozoite stage, or growth stage, and then at 38 
hours they reach the third and final stage, the schizont stage. This is when the parasite 
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starts to multiply until there are several merozoites. When the daughter merozoites are 
fully mature, usually at around 48 hours post invasion for P. falciparum, the 
erythrocyte cell bursts, releasing merozoites which invade more erythrocytes. This 
process repeats itself until either the host dies or the parasite is controlled by 
chemotherapy or the immune response. Some merozoites, after invasion into 
erythrocytes, undergo an alternative pathway of differentiation; they differentiate into 
female or male gametocytes, which can be taken up in a mosquito blood meal. It takes 
6 to 10 days for the gametocytes to reach a mature state that is infective to the 
mosquito. Following the blood meal, the gametocytes are released from the 
erythrocyte and fuse to form a zygote. Differentiation and growth occurs, leading to 
the production of infective sporozoites in the salivary glands of the mosquito, here 
they wait for the mosquito to take its next blood meal (Refer to Figure 1A from Scherf 
et al. 2008) (Kyes et al. 2001, Miller et al. 2002, Garcia 2010, Silamut et al. 1999).  
1.1.5 Pathogenesis and clinical features 
 
Malaria is an acute febrile illness. The most frequent clinical features in 
malaria are fever, chills, fatigue, malaise, headaches, abdominal discomfort, 
perspiration, nausea, vomiting, and muscle and joint pain. The onset of malaria attack 
occurs 8-12 days after infection, when the parasite has entered the blood stage of its 
life cycle, and is characterized by 3 to 4 days of vague symptoms, such as aches, pains 
and headache. This stage is then followed by fever, a more severe headache, nausea 
and vomiting. An untreated primary attack of P. falciparum ends after 2-3 weeks. 
However, severe or fatal complications can occur at any time (Garcia 2010). The 
development of severe malaria is believed to result from several parasite-specific 
factors, such as cytoadherance and sequestration in the vasculature and the release of 
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bioactive molecules, in combination with host inflammatory responses, including 
cytokine and chemokine production (Mackintosh et al. 2004, WHO 2010a). By 
binding to different types of host cells (cytoadherence) the parasite is able to sequester 
into different organs, and ultimately contributes to the life-threatening properties of 
the disease, as it prevents the removal of these parasites via the spleen and leaves 
them in a favourable environment, allowing them to replicate and as such results in 
microvasculature occlusion, tissue hypoxia and severe complications due to the 
resulting restriction of blood flow (Jemmely et al. 2010). Antigenic variation, whereby 
certain families of parasite proteins on the erythrocyte surface switch their expression 
from one dominant variant to another is the cause for the waves of parasitemia typical 
of P. falciparum infection and the persistence of the disease since the immune system 
does not recognize this new variant antigen (Blythe et al. 2004, Pasternak and 
Dzikowski 2008). Rosetting is also observed in P. falciparum infections, which is 
when infected erythrocytes bind to neighbouring uninfected erythrocytes, and may 
block capillary blood flow. It has been correlated with severe disease, the 
development of high levels of parasitemia and most notably cerebral malaria. Cases of 
mild malaria attack have been found to have anti-rosetting activity in the plasma, 
whereas in cerebral malaria cases, no such, or very little, anti-rosetting activity has 
been observed (Jemmely et al. 2010, Heddini et al. 2001, Garcia 2010). Cerebral 
malaria is the most severe neurological complication of P. falciparum. It is most 
common in children living in sub-Saharan Africa, but is also a concern for non-
immune adults. The essential component is the sequestration of infected erythrocytes 
with parasites that are in the trophozoite and schizont stages within cerebral blood 
vessels. For those who survive, subsequent neurocognitive impairment is most 
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common and most severe in children (Idro et al. 2005). Thus this obstruction of blood 
flow and the localized immune response are both thought to be responsible for the 
severe complications of cerebral malaria, but also for another severe form of the 
disease: pregnancy-associated malaria (PAM) (Dzikowski and Deitsch 2008). Malaria 
in pregnancy is associated with infected erythrocytes accumulating in the intervillous 
blood spaces of the placenta through the adhesion to specific molecules; a conserved 
parasite gene var2csa has been associated with this form of malaria, and might be an 
appropriate vaccine candidate. Placental malaria often leads to premature delivery, 
low birth weight and increased mortality in the newborn and severe anemia in the 
mother (Rogerson et al. 2007, Miller et al. 2002, Pasternak and Dzikowski 2008). 
Other forms of severe malaria include metabolic acidosis, severe anemia, 
hypoglycaemia, acute renal failure or pulmonary edema. In cases of severe malaria, 
approximately 10-20% of individuals receiving treatment die. However, if left 
untreated severe malaria is in most cases fatal (WHO 2010a). Therefore, following 
infection with P. falciparum the patient will either die in the acute attack or survive 
and develop some immunity (Grobusch and Kremsner 2005).  
1.1.6 Diagnostics 
There are several diagnostic tests used to confirm P. falciparum infection. The 
main one that has been used for over a century is microscopic examination of thin and 
thick Giemsa stains. Although inexpensive, it is laborious and requires an experienced 
microscopist, as the sensitivity and specificity of the test is quite low, but it can be 
used for speciation and parasite quantification. Immunochromatographic tests (ICT), 
also known as rapid diagnostic tests (RCTs) were developed in the early 1990s to 
detect parasite-specific antigen or enzymes in the blood by monoclonal antibody 
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binding. In these tests the antigen or enzyme and its specific monoclonal antibody 
form a complex that travels by lateral flow along a nitrocellulose strip where the 
antigen can be captured by immobilized antibodies producing a visible band in a 
positive test. As the name suggests these tests are fast, but there are issues with 
regards to their sensitivity and specificity and they are vulnerable to high temperatures 
and humidity. Other diagnostic methods include nucleic acid based tests, such as 
PCR, real-time PCR and quantitative nucleic acid sequence-based amplification (QT-
NASBA). Mass spectroscopy is another diagnostic test; it measures for the presence 
of hemozoin, an insoluble heme polymer produced by malaria parasites. Mass 
spectroscopy is rapid and has a high specificity. Flow cytometry is another method; it 
can measure for the presence of hemozoin or pathogenic antigens (Erdman and Kain, 
2008, WHO 2010a). 
1.1.7 Prevention 
As malaria is primarily transmitted by mosquito bites, protection against 
mosquito bites is key; thus wearing mosquito repellent with N,N-diethyl-3-
methylbenzamide (DEET), wearing long-sleeved shirts and pants, as well as footwear 
that provides full coverage, and sleeping in screened areas or under insecticide treated 
bed-nets is essential. If bitten, chemoprophylaxis is an option used to prevent primary 
clinical attacks of all five species that cause malaria. Most regimens provide 75% to 
95% protection, if taken correctly; however, there is no chemoprophylactic regimen 
that is 100% effective against clinical attacks of malaria. The drugs of choice are 
atovaquone-proguanil, artemether-lumefantrine, quinine plus dooxycycline or 
clindamycin, mefloquine and chloroquine (in non-resistant areas). (Chen et al. 2006, 
Freedman 2008, WHO 2010a). At a community level, vector control is the primary 
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intervention that can be used in reducing transmission of malaria. Indoor residual 
spraying with insecticides is very effective in reducing this transmission if at least 
80% of houses in targeted areas are sprayed. Community wide distribution and 
compliance in use of insecticide treated bed-nets is another effective method for 
vector control (WHO 2010b).  
1.1.8 Treatment 
The main form of treatment for malaria is the administration of anti-malarial 
drugs. There are several classes of drugs used for the treatment of malaria: 4-
aminoquinolines, arylaminoalcohols, 8-aminoquinolines, artemisinines, antifolates 
and inhibitors of the respiratory chain and antibiotics (Schlitzer 2008). The 
recommended treatment option for uncomplicated P. falciparum cases is by 
artemisinin-based combination therapies (ACTs), including artemether-lumefantrine 
(Coartem), artesunate-amodiaquine, artesunate-mefloquine, and artesunate-
sulfadoxine-pyrimethamine. In severe P. falciparum cases artesunate or quinine 
administered intravenously has been recommended, followed by a complete course of 
an ACT or artesunate plus clindamycin or doxycline. For years chloroquine, and 
sulfadoxine-pyrimethamine were used, but resistance to these drugs have increased to 
such an extent that they are in most cases no longer a viable option. For travellers 
from non-endemic countries, atovaquone-proguanil, artemether-lumefantrine, 
dihydroartemisinin plus piperaquins are recommended for uncomplicated malaria 






1.2 Multi-gene families of Plasmodium falciparum 
1.2.1 Structure and function of multi-gene families var, rif and stevor in  
         P. falciparum 
 
Following the release of the first complete genome sequence of P. falciparum, 
it was noted that a significant proportion of the parasite‟s genome was dedicated to 
multi-gene families. Furthermore, the high sequence diversity of proteins encoded by 
these genes families suggests their importance in immune evasion strategies allowing 
the parasite to establish long lasting chronic infections (Blythe et al. 2004, Jemmely et 
al. 2010). Several large multi-gene families have been identified in P. falciparum, 
with three major families: var, rif, and stevor (Blythe et al. 2009, Scherf et al. 2008). 
All of these multi-gene families are thought to play a role in pathogenicity through 
cytoadherence and invasion, and to also play a role in the parasite‟s survival, through 
antigenic variation (Blythe et al. 2004, Pasternak and Dzikowski 2009). Multi-gene 
families are found in the sub-telomeric regions of all 14 chromosomes, with the 
exception of some var genes, which are located at several internal clusters of some 
chromosomes, (Refer to Figure 2 A from Scherf et al. 2008) (Kyes et al. 2001). 
In P. falciparum the most well characterized multi-gene family is the var gene 
family, encoding for P. falciparum Erythrocyte Membrane Protein-1 (PfEMP1), 
which range in size between 200 and 350 kDa. There are approximately 60 var genes 
per genome, and they are 6-13 kb in length. The genes are mostly in subtelomeric 
regions but also in central regions of the chromosomes, and are divided into 
subclasses based on their 5‟ UTR sequence alignment (ups). All var genes share a 
similar structure of a long first exon, encoding the variable extracellular domain of 
PfEMP1, a well-conserved intron and a short exon that codes for an acid terminal 
segment that anchors the protein into the cytoskeleton of the erythrocyte membrane 
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(Refer to Figure 2 B from Scherf et al. 2008). The main structural features conserved 
among all PfEMP1 proteins include an N-terminal segment, variable numbers of 
Duffy Binding Like domains (DBL, α-ε), one or two cysteine-rich inter-domain 
regions (CIDR α-ε), a trans-membrane domain, a C2 domain, and a conserved intra-
cellular acidic terminal segment. There is extreme sequence diversity in the DBL and 
the CIDR extracellular adhesion domains among PfEMP1 proteins as they are 
exposed to constant selection pressure by the human immune response. These 
domains have an ability to bind to a variety of host receptors, as such the var genes 
encode for PfEMP1 proteins that have unique antigenic and cytoadherance properties 
(Sharp et al. 2006, Pasternak and Dzikowski 2009, Calderwood et al. 2003). Var 
genes are transcribed very early in the blood stage of the parasite, approximately 3 
hours after invasion and are the first parasite antigens exposed at the erythrocyte 
surface at 18 hours post-invasion (Scherf et al. 2008).  
Like the other multi-gene families, PfEMP1 is clonally variant, allowing it to 
evade host cell immunity (Kaviratne et al. 2002). Its main role is thought to be in 
cytoadherence of infected erythrocytes to many different host cells on the vascular 
lining during the blood stage of the infection, since it is expressed on the surface of 
erythrocytes in knob-like structures from which it can bind to various host adhesins. It 
is also believed to mediate rosetting and has a role in the antibody-dependent immune 
response. This response clears most of the infected cells, as the majority are 
expressing the same PfEMP1 variant, but there are small sub-populations of parasites 
that switch their expression to a different PfEMP1, resulting in the re-establishment of 
infection and thus the persistence of infection. This whole process is known as 
antigenic variation and is a mechanism of immune evasion by the parasite (Pasternak 
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and Dzikowski, 2009, Jemmely et al. 2010). Since PfEMP1 undergoes antigenic 
variation and is the major antigen that mediates cytoadherance and also has a role in 
resetting, it is considered to be one of the most serious virulence factors of 
P.falciparum. It has also been proposed to be one of the main targets for naturally 
acquired immunity to malaria (Bull and Marsh 2002). 
The largest multi-gene family in P. falciparum is that of the repetitive 
interspersed family (rif) gene family, represented by approximately 150 copies in the 
3D7 genome. Their gene structure consists of an exon with a start codon and a signal 
sequence, followed by an intron and another exon. These genes are located in the 
subtelomeric regions of all 14 chromosomes (Refer to Figure 2 A from Scherf et al. 
2008). They code for membrane proteins (RIFINS) of 27-45 kDa in size, and have a 
two-transmembrane (2TM) topology (Kyes et al. 1999, Scherf et al. 2008, Marti et al. 
2004). They have been divided into two major subgroups: A- and B- type RIFINS, 
which differ in their structure and possibly their function as well (Figure 1.2). A-type 
appear to be exported via Maurer‟s clefts (MCs) to the erythrocyte membrane, B-type 
RIFINs remain in the parasite cytosol (Jemmely et al. 2010, Khattab and Klinkert 
2006). Maurer‟s clefts are parasite derived membranous protein sorting structures 
located in the infected erythrocyte cytoplasm that have been implicated in transport of 
proteins to the surface of the erythrocyte (Scherf et al. 2008, Marti et al. 2004, Blythe 
et al. 2004). They have been shown to be expressed in sporozoites and gametocytes as 
well. Differential expression patterns between A- and B- type RIFINS was observed in 
gametocytes and an upregulation of a subset of rif genes was observed in the 
sporozoite stage (Florens et al. 2002 and Petter et al. 2008). They are clonally variant 
and since they are targeted to the surface of infected erythrocytes in the asexual stage 
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of infection they are inevitably targets of the human immune response, but the exact 
functional role of RIFINS is still unknown. There have been suggestions that they 
have a role in antigenic variation, since they have been shown to undergo expression 
switching. (Abdel-Latif et al. 2002, Tham et al. 2007, Jemmely et al. 2010, Kyes et al. 
1999). 
Sub-telomeric Open Reading Frame (STEVOR) proteins are structurally 
similar to RIFIN proteins, however they are transcribed and expressed much later in 
the blood stage than both var and rif genes, and the PfEMP1 and RIFIN proteins, 
respectively (Kaviratne et al. 2002, Jemmely et al. 2010). STEVOR was first reported 
in 1991, when it was identified as an expressed sequence detected by a monoclonal 
antibody 7H8 in P. falciparum (Limpaiboon et al. 1991). The stevor gene has 33 
copies in the 3D7 clone, and like the rif gene family, stevor genes have a two exon 
structure: a short first exon that encodes a start codon and a signal sequence, followed 
by an intron and then another exon, which is shorter than that found in rif genes and 
encodes for highly conserved sequences interspersed within a single variable region. 
These genes are located subtelomerically on all 14 chromosomes (Refer to Figure 2 A 
from Scherf et al. 2008). Each stevor gene encodes for a 30-40 kDa protein (Kaviratne 
et al. 2002, Blythe et al., 2004, Marti et al. 2004). It is predicted to possess two trans-
membrane domains that are flanking a hyper-variable region; this structure is similar 
to that of RIFIN, as they both have a predicted 2TM topology (Figure 1.2) (Jemmely 
et al. 2010). However, Niang and colleagues (2009) challenged this actual predicted 
2TM topology of STEVOR, and suggest a topology as shown in Figure 1.3, models 2 
to 4, or model 1, a 2TM topology where the hyper-variable region is on the 
erythrocyte cytoplasmic side of the membrane. Multiple stevor genes are transcribed 
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during a short developmental window (22-32 h) after invasion, with peak transcription 
occurring at the mid-trophozoite stage (28 h) (Figure 1.4) (Kaviratne et al. 2002). 
However, correctly spliced stevor transcripts have been detected as late as the early 
schizont stage using RT-PCR (Cheng et al. 1998). Several stevor genes are 
transcribed by a single parasite, and only a subset of stevor is transcribed at one given 
time in cultured parasite populations (Niang et al., 2009, Sharp et al. 2006 and 
Kaviratne et al. 2002). In the late trophozoite to late schizont stages STEVOR is 
located in the MC, and in the late schizont stage it can also be located in the infected 
erythrocyte surface (Kaviratne et al. 2002, Przyborski et al. 2005, Blythe et al. 2008). 
STEVOR is also expressed in the merozoites, and they are located in merozoites‟ 
apical ends, as well as in gametocytes and sporozoites (Kaviratne et al. 2002, Blythe 
et al. 2008, Khattab et al. 2008, McRobert et al. 2004, Sharp et al. 2006). This 
ubiquitous expression of STEVOR in most of the life stages of the parasite suggests 
its importance in the parasite‟s survival. Furthermore, Blythe and colleagues have 
shown that the STEVOR expression level is even higher in field isolates in 
comparison to long-term cultured parasites (2008). The hypervariable region of 
STEVOR has been shown to be under strong selection pressure as a high sequence 
variability was found within the hypervariable regions among different STEVORs 
based on sequence alignment and phylogenetic studies (Jemmely et al. 2010, Lavazec 
et al. 2007). It is clonally variant and has switch rates similar to that of var genes 
(Lavazec et al. 2007). The exact role of STEVOR is still debated, but there have been 
suggestions that it, along with PfEMP1 and RIFIN proteins, participates in antigenic 
variation and there have been suggestions that it may mediate some adhesion 
functions in gametocytes and sporozoites (Lavazec et al. 2007, Niang et al. 2009, 
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Blythe et al. 2004, Kyes et al. 1999). The role of STEVOR in generating clinical 
immunity is still not known, although there has been a cross-sectional study of 90 9-
month old Ghanian infants using 1 recombinant STEVOR that showed that the 
number of antibody responses correlated with the number of parasitemia episodes, but 
an overall protective effect could not be attributed to antibodies against this STEVOR 
(Schreiber et al. 2008). 
 
 
Figure 1.2 Structure of rif_A and rif_B  and stevor  
There are two possible versions of stevor, both possess a signal sequence and PEXEL motif, but one 
version suggests that there are 2TM domains flanking a hyper-variable region. The other version 











Figure 1.3 Models of membrane topologies for STEVOR proteins  
Model 1 suggests that the protein has 2TM domains, where as Model 2 – 4 all only have one TM 
domain and the N-terminal-most hydrophobic region (purple) is either exposed (model 2), associated 
with the lipid bilayer (model 3) or is associated with the globular domain (model 4). It is also possible 




Figure 1.4 Overview of predominant transcription and protein expression time points of the var, stevor, 
and rif multi-gene families during the blood stage of P. falciparum  
(Scherf et al. 2008, courtesy Yeo Pin Kim) 
 
 
1.2.2 Transcriptional regulation mechanisms in the multi-gene families: var, rif 
and stevor of P. falciparum 
 
The phenomenon of antigenic variation is a major survival strategy of many 
pathogens that develops due to the constant onslaught of the host immune response. In 
P. falciparum this immune evasion strategy consists of the coordinated expression of 
variant surface molecules on the infected erythrocyte, which ends up diminishing the 
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clearance by the host antibody response leading to persistent infections, with 
successive waves of parasitemia. There has been extensive research in the 
transcriptional regulation mechanisms coordinating the process of antigenic variation 
in one of these families, namely the var gene family (Scherf et al. 2008). 
The expression of var genes is regulated at the level of transcription initiation 
(Scherf et al. 1998). It was found that switches in expression were not accompanied 
by promoter DNA sequence alterations and were probably also not the result of 
changes in transcription factors (Deitsch et al. 1999). Chromosomal position also does 
not dictate expression of var genes, as transcriptionally active var genes have been 
found adjacent to silent copies (Calderwood et al. 2003). Many aspects of var gene 
family transcriptional regulation have been identified though, including noncoding 
RNAs, chromatin remodeling and promoter-promoter interactions, these components 
all contribute in the activation, silencing and mutually exclusive expression of this 
gene family (Jemmely et al. 2010). Mutually exclusive expression is when cells 
express only one single member of a multi-gene family. In the case of the multi-copy 
var gene family expression, this results in only one antigenic form of PfEMP1 
expressed on the infected cell surface at a time (Kyes et al. 2001). It is believed that 
without such exclusion there would be a premature expenditure of the antigenic 
repertoire, as all copies would be expressed simultaneously, and incomplete silencing 
of previously expressed copies would lead to clearance by antibodies that were 
generated against them (Calderwood et al. 2003). Furthermore, there is evidence of 
another mechanism involved in the activation of this gene family, namely that 
subnuclear positioning might be important in var gene activation, in the case of var 
genes they found that active var promoters co-localize to a specific spot in the 
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periphery of the parasite nucleus. This type of localization has been shown to play a 
role in the mutually exclusive expression of another organism, African Trypanosomes 
(Howitt et al. 2009). There have been significant advancements in our understanding 
of promoter-promoter interactions and their role in var transcriptional regulation and 
how they relate to mutually exclusive expression. The model of mutually exclusive 
expression of a single var gene during transcription has been up until very recently a 
long held belief in the P. falciparum research community (Joergenson et al. 2010). 
One study on the mechanism of this silencing of var genes found that it is associated 
with the presence of a var intron. They showed that this silencing is established during 
the DNA-synthesis phase (S phase) of the cell cycle (occurs in the late trophozoite 
stage) and that it involves the cooperative interaction between two elements in 
separate control regions of each var gene, namely the 5‟UTR and the intron. They 
made two different constructs containing a luciferase reporter driven either by a var 
promoter sequence or by a promoter from an unrelated gene hrp3, which encodes a 
histidine-rich protein 3, (pVlh, and pHLH, respectively). The transfection experiments 
showed that when the var intron was present and downstream with respect to the 
luciferase gene, the luciferase signal was strongly repressed, irrespective of var intron 
orientation. But when the var intron was present in the pHLH construct, there was no 
change in the reporter activity. They then performed another experiment where they 
looked at the reporter activity before and after the S phase. Transition through the S 
phase of the cell cycle is known to be required for the assembly of silent chromatin 
structures in other organisms. They performed assays at 18 hours after invasion 
(before the onset of S phase) and after separating the transfected parasites from 
plasmid-loaded erythrocytes in the late schizont stages, they allowed these parasites to 
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invade fresh plasmid-free erythrocytes. This ensured that all plasmid DNA in the 
parasites had been through the S phase. They observed a complete repression of the 
reporter construct in pVlh with downstream intron, but there was no silencing in the 
control transfections with the original pVlh. Thus they showed that the control of var 
gene transcription involves cooperative DNA-binding complexes, in this case var 
promoters in cis with var introns, and modifications of chromatin structure (Deitsch et 
al. 2001). Other studies also showed that the intron had a role in the epigenetic 
silencing of var gene expression (Calderwood et al. 2003, Gannoun-Zaki et al. 2005, 
Frank et al. 2006). Calderwood and colleagues later identified that the var intron has 
promoter activity, and suggested that it could be functioning as both a silencer as well 
as a boundary element that separates each var gene from the neighbouring chromatin 
environment. To be more precise, transcription from the var introns occurs later in the 
cell cycle than the ring-stage peak of upstream var promoter activity, and it results in 
“sterile” transcripts associated with the intron and Exon 2, it is these transcripts that 
may have a role in silencing of var genes and as well as acting as insulators, 
separating the transcriptionally active and silent chromatin domains of the 
chromosome segments where var genes reside (2003). This research group later 
identified that it is the promoter activity itself, rather than the DNA sequence that is 
responsible for the ability of the intron to silence a var gene and again silencing was 
S-phase dependent, as they found that heterologous promoters can be used for co-
operative regulation of var gene regulation instead of the var intron. As such it seems 
that these gene promoters in close proximity to a var promoter seem to somehow 
interact directly or indirectly with this upstream var promoter (Figure 1.5). 
Furthermore, they found that any unpaired var promoter activity uncouples it from the 
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parasite counting machinery, that is they were constitutively active and mutually 
exclusive expression was abolished. They also identified a var specific subnuclear 
expression site near the nuclear periphery and found that it is capable of 
accommodating several transcriptionally active var promoters, thus this is not the 
restricted accommodative capacity of the expression site alone that explains mutually 
exclusive expression of var genes (Dzikowski et al. 2007).  
 
Figure 1.5 Summary of Dzikowski and colleagues experiment supporting the var silencing intron-
mediated repression hypothesis (A) pVlh var promoter has no downstream promoter, thus it is unpaired, 
in all other constructs they are paired, either with the intron, or with some active blood stage promoter, 
(B and C) After the S phase all coupled promoters were silenced (Adapted from Dzikowski et al. 2007). 
 
There have been some studies that have challenged the postulated role of the var 
intron in silencing and counting by investigating endogenous var genes. Thus there is 
still considerable work that needs to be done to understand the role of the var intron 
(Scherf et al. 2008). As previously mentioned, the model of mutually exclusive 
expression of var genes has also been challenged. It was thought that in the late blood 
stages each individual parasite expresses a single var gene at a time maintaining the 
remaining in a transcriptionally silent state. Joergensen and colleagues found that two 
different PfEMP1 antigens on a single P. falciparum-infected erythrocyte and that this 
parasite bound to two host adhesion factors, CD31/PECAM1 and CD54/ICAM1 and 
that these parasites adhered twice as efficiently to human endothelial cells compared 
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to infected cells having only one PfEMP1 variant on the surface (2010). This new data 
indicates that the molecular mechanisms in P. falciparum adhesion and the var gene 
regulation model of absolute mutually exclusive var gene transcription are more 
complex than previously thought.  
In contrast to var genes, the regulation of transcription in both rif and stevor 
genes families is still poorly understood. The transcriptional regulation of rif genes is 
limited to one study by Tham and colleagues (2007). They identified a transcriptional 
start site of a rif gene and also a functional promoter within this region through 
transient transfection luciferase assay experiments. They also identified two distinct 
regions within this upstream region that are involved in the transcriptional repression 
of these genes. Furthermore, they showed that these repressor elements bound nuclear 
proteins in different stages of the P. falciparum life cycle, possibly suggesting that one 
repressor element is responsible for selective repression of rif genes early in the life 
cycle, that is before the late ring stage, and another repressor element is responsible 
for the repression of rif genes in later stages of the life cycle, which would be past the 
early trophozoite stage. They further identified that the transcriptional profiles of var 
genes with an upsA promoter and their neighbouring rif genes are not transcriptionally 
co-regulated (Tham et al. 2007).  
 The mechanism for the regulation of stevor gene transcription is even less 
understood than the rif multi-gene family. Since stevor is only transcribed after 22 
hours in the asexual blood stage of the parasite‟s life cycle it is believed that there is a 
precise mechanism for the regulation of its expression. There are only a few studies 
that have attempted to understand this mechanism (Lavazec et al. 2007, Sharp et al. 
2006, Howitt et al. 2009). Based on evidence from whole-parasite cultures it was 
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found that not all members of this gene family are transcribed concurrently, 
suggesting that some are silenced within a single parasite, while others are active. 
There have been studies that have investigated whether stevor gene transcription is 
linked to the expression of a unique var gene, but there was no evidence of a link in 
transcriptional regulation between these two gene families in both sexual and asexual 
parasites (Sharp et al. 2006). Although to date there have been no specific cis-acting 
gene control elements that have been reported to specifically control stevor gene 
expression, there is an indication that all three families may share common 
transcription factors, thus it appears that there is an overall conserved mechanism that 
regulates all three multi-gene families. In this study Howitt and colleagues showed 
that down-regulation of var gene expression using a promoter titration method 
resulted in the down-regulation of other multicopy gene families, including rif and 
stevor of P. falciparum and they further identified a common titratable factor 
necessary for their expression (Howitt et al. 2009). Finally, another aspect of the 
stevor gene family that has not been characterized is their 5‟UTR lengths. The 
5‟UTRs of both var and rif multi-gene families has been determined with a 
transcription start site at -1167, and -200 to -245, respectively (Horrocks et al. 2009).  
1.3 Aims of project 
 
The aim of the project was to understand how stevor transcription is regulated. 
The approach in this study was to first see if it is controlled through a similar 
mechanism as that observed with the var genes; that is to see if stevor also undergoes 
intron-mediated repression, either by its own intron or by a var intron. First, transient 
transfection standardization experiments using two constructs with a chloroquine 
resistance transporter promoter from P. falciparum 3D7 located upstream from either 
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a firefly luciferase gene or a renilla luciferase gene were performed. After several 
failed transfection experiments, alternative constructs that had a 5‟UTR and a 3‟UTR 
of the actin gene PFL 2215 of P. falciparum immediately upstream and downstream, 
respectively, of either a firefly luciferase gene or a renilla luciferase gene were used 
for subsequent standardization transient transfection experiments. With successful 
reporter signals observed with both of these constructs, transient transfection 
experiments using constructs with a firefly luciferase gene under the control of a 
stevor promoter, a segment of its gene (PFB 1020w) and a downstream var intron 
were compared with an almost identical construct, except it lacked a downstream var 
intron. The resulting reporter signals with these constructs under the control of this 
stevor promoter were similar to the negative controls. As such, newly made constructs 
with a different stevor gene, PF10_0395, that included a longer upstream promoter 
region were cloned into the same backbone as the previous stevor construct (PFB 
1020w). After several unsuccessful transfections with these new constructs, 
troubleshooting transfections were performed, and it was determined that transfection 
be performed prior to six hours post-invasion. Repeat experiments with these new 
stevor constructs were performed and were successful. For all transient transfections 
measurements were made by performing luciferase assays. Finally, as little is known 
about stevor gene transcription regulation, a first step is to characterize the 5‟UTR 
lengths, as has been determined for the other two main multi-gene families of P. 
falciparum. Therefore, 5‟RACE experiments was performed on three selected stevor 

































Chapter 2: Materials & Methods 
2.1 Plasmodium falciparum 3D7 strain culture and experiments 
         2.1.1 Cultivation of P. falciparum 3D7 
Plasmodium falciparum 3D7 strain was used in all transient transfection 
experiments. A frozen stock of 3D7 parasites was thawed; stocks are stored in liquid 
nitrogen and they are synchronized to be in the ring stage. Cultivation is based on 
Trager and Jenson‟s technique (1976). Components of the parasite culture media are 
outlined in Table 2.1. Incomplete RPMI (iRPMI) was used as a washing medium for 
fresh erythrocytes and infected erythrocytes (ERs). Complete RPMI (cRPMI) was 
replaced daily and fresh erythrocytes were added as required. For the preparation of 
transfection the parasites were cultured in 175cm
2
 flasks (NUNC, Denmark) at 1% 
haematocrit, consisting of 2 ml pellet in 200 ml of cRPMI. After transfection the 
parasites were grown in 25 cm
2
 flasks (NUNC). The parasite was maintained under 
low oxygen conditions of 88% nitrogen, 5% oxygen and 7% carbon dioxide by 
gassing the flask with this mixture for 5-10 sec before placing it into the 37°C 
incubator for growth (Thermo Election Corporation, USA). 
Table 2.1 Components of P. falciparum media 
Components Complete RPMI Incomplete RPMI 
RPMI-1640 (Gibco, USA) 16.2 g/L 16.2 g/L 
Sodium Bicarbonate (Sigma, USA) 2.3 g/L 2.3 g/L 
Albumax II (Gibco) 2.5 g/L None 
Hypoxanthine (Sigma)* 0.05 g/L None 
Gentamycin (Gibco) 50 mg/L 50 mg/L 
MilliQ H2O 1 L 1 L 




Parasitemia was determined by adding 5 µl of the culture (at 50% haematocrit) 
to a slide and spread evenly into a thin film. The slide was then fixed by immersion in 
methanol (Merck, USA) for 10-20 sec and then air-dried. Filtered 20% (1 in 5 dilution 
1X TAE buffer) Giemsa stain (Sigma, USA) was applied to the slide and left for 5 
min. The slide was then rinsed under tap water and dried. The smear was then 
observed using immersion oil at 1000x magnification (Olympus, Japan). At least 1000 
erythrocytes were counted. Parasitemia for tranfection was between 5-10%. The 
percentage of parasitemia was determined as follows: 
Parasitemia =   
No. of infected erythrocytes 
No. of total erythrocytes   x 100 % 
 
2.1.3 Blood preparation 
Blood was donated from a malaria negative donor. 350 ml of blood was drawn 
into a blood bag containing anti-coagulant detergent (ACD). Before being added to 
the parasite culture, the serum, and ACD were removed and the blood was then 
washed three times with iRPMI. After each washing step the blood was centrifuged at 
2200 rpm for 5 min and the subsequent supernatant was removed. After each 
centrifugation a thin layer of blood at the top was carefully aspirated as well in order 
to ensure that leukocytes were removed. After the final centrifugation and removal of 
supernatant an equal volume of iRPMI was added to the blood, resulting in 50% 
hematocrit and stored at 4°C for up to 30 days.  
2.1.4 SuperMACS synchronization 
CS columns (MACS Miltenyi Biotec, USA) were used to separate early to mid-
schizonts from other blood stages of 3D7. Set-up was according to the manufacturer‟s 
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protocol. The column was first rinsed with 10 ml of iRPMI. Pelleted infected 
erythrocytes (iERs) were re-suspended in 5 ml of iRPMI (1 ml pellet = 5 ml iRPMI) 
and added to the column. Once the iERs were in the column, it was washed with 20 
ml of iRPMI and then removed from the magnetic field of the MACS separator. 
Another 20 ml of iRPMI was then added to wash out the schizonts. The procedure 
was repeated with the same CS column up to a maximum of four times. The wash 
extract and the schizont extract were centrifuged at 2200 rpm for 5 min and 
supernatant was removed. Fresh blood and cRPMI were added to make 1-2% 
haematocrit and then each culture was placed back into the 37°C incubator after being 
gassed. 
2.1.5 Sorbitol synchronization 
Sorbitol synchronization of P. falciparum blood-stage parasites was first 
established by Lambros and Vanderburg (1979). SuperMACS synchronized iERs 
were treated with 5% sorbitol (5% sorbitol was made using 1x PBS from 20% sorbitol 
stock solution) after they had re-invaded and were in the ring stage. This ring-stage 
parasite culture was first centrifuged at 2200 rpm for 3 min in 50 ml Falcon tubes 
(BD, USA), supernatant was removed and 5 ml of 5% sorbitol (equilibrated to 37°C) 
was added to each 1 ml of iER pellet. Following 1 min of vigorous mixing the 50 ml 
Falcon tube was incubated in the 37°C water bath for 5 min. The mixture was then 
centrifuged three times at 2200 rpm for 5 min. Following each centrifugation the 
supernatant was removed; taking care to remove the top layer of the iER pellet, which 
contained dead ERs, and 10 ml of iRPMI was added for washing each time. The 
culture was re-suspended in cRPMI to 1-2% haematocrit with fresh blood added when 
necessary and placed into the 37°C incubator for growth after gassing. 
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2.1.6 Transient transfection of P. falciparum parasites 
Transfection of malaria parasites is based on the technique by Wu et al. 
(1995). In this study only transient transfections were performed, as such transfection 
refers to transient transfections only. Transfection was performed in the very early ring 
stage (up to 6 hours post-invasion) at 5-10% parasitemia. These parasites were 
synchronized in the following order: schizonts were extracted by using CS 
SuperMACS columns, these schizonts were then allowed to invade fresh erythrocytes, 
8-18 hours post-invasion these iERs were further synchronized using 5% sorbitol. 
Both synchronization steps were performed in order to have a healthy and very 
synchronized parasite culture. Following this synchronization these ring-stage 
parasites were left until they had re-invaded again (up to 6 hours post-invasion).The 
synchronization of the parasite, the early ring stage transfection and the level of 
parasitemia of 5-10% were all required to ensure the transfection efficiency was not 
affected by the number of parasites growing nor the percentage of mid-to-late ring 
stage parasites. Once in the early ring-stage these iERs were centrifuged at 2200 rpm 
for 3 min, supernatant was removed, and the percentage of parasitemia was 
determined and diluted accordingly to 5-10%, if applicable. 200 µl of infected ERs 
was added to a 1.5 ml microcentrifuge tube containing 300 µl of 2x cytomix and a 
total of 100 µg of plasmid DNA. The 2x cytomix was prepared as described by 
Maurice et al. (1992) (1x cytomix: 120 mM KCl, 0.15 mM CaCl2, 10 mM 
K2HPO4/KH2PO4, 25 mM HEPES/2mM  EGTA and 5 mM MgCl2; pH 7.6, adjusted 
with KOH, sterile, stored 4°C). Contents were mixed and added to 0.2 cm gap 
electroporation cuvettes (Bio-Rad, USA), which were then placed on ice for no more 
than 30 sec, dried well and then pulsed using Bio-Rad Gene Pulser Xcell Total 
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Electroporation System (Bio-Rad), at 310 V, 950 µF capacitance and 0 Ω. 
Electroporation voltage and time constant values were recorded, time constants 
between 7-11 milliseconds had to be maintained for sufficient transfection efficiency. 
Immediately after electroporation 2 ml of cRPMI was added to each cuvette and the 
contents were carefully put into 25cm
2
 flasks containing 8 ml of cRPMI and 200 µl of 
50% ERs. Flasks were gassed, sealed, and placed into the 37°C incubator. Parasite 
media was changed 3-10 hours after transfection. Parasites were harvested for 
luciferase assays at various stages depending on the experiment. 
2.1.7 Dual-luciferase assay 
Dual-luciferase assays were performed at various stages as required by the 
experiment design. Most assays were performed in the schizont stage (40-48 hours 
post-invasion). The kit used was Promega‟s Dual-Luciferase Reporter Assay kit 
(USA). The contents of each 25 cm
2
 flask were placed into 15 ml falcon tubes (BD) 
and centrifuged at 2200 rpm for 5 min. Supernatant was removed and 1 ml of 0.15% 
saponin (Fluka, USA) was added to lyse the ERs; the tubes were mixed well and then 
placed on ice for 10 min. Following the incubation 5 ml of 1x PBS at a pH of 7.4 was 
added and the tubes were centrifuged at 2800 rpm for 5 min. The parasite pellet was 
washed again with 5 ml of 1x PBS and spun again at 2800 rpm for 5 min. Supernatant 
was removed and the pellet was resuspended in 1 ml of 1x PBS and transferred to 1.5 
ml microcentrifuge tubes. Parasites were pelleted at 4000 rpm for 5 min. 100 µl of 1x 
Passive lysis buffer (PLB) from the kit was added to the parasite pellet and tubes were 
placed on ice for 10 min, but at 2 min intervals they were removed and vortexed. 
Vortexing was performed in order to ensure sufficient lysis of the parasite. The dual 
luciferase assay was performed according to the manufacturer‟s protocol; after the 
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addition of firefly luciferase reagent, known as LAR II, the mixture was pipetted two 
times (volume 100µl) to ensure proper mixing. 100 µl the renilla luciferase reagent, 
known as Stop and Glow reagent, was added immediately after the firefly luciferase 
measurements were complete and vortexed before measurements were performed. The 
luminescence was measured using a Glomax 20/20 Luminometer (Promega), with 
three measurements made after the addition of each substrate. Measurements were 
performed as quickly as possible following the addition of each substrate. 
2.1.8 DNA extractions from cultured P. falciparum 3D7 
P. falciparum 3D7 parasites were centrifuged at 2200 rpm for 3 min. Supernatant 
was removed and the iER pellet was used for genomic DNA extractions using Genomic 
DNA Purification kit (Fermentas, Canada). The manufacturer‟s protocol was followed. 
Cold ethanol was used for precipitation. The DNA pellet was dried to the point where it 
was transparent, and then re-suspended in 100 µl of TE buffer. The concentration was 
measured and only genomic DNA with 260/280 and 260/230 ratios between 1.8-2.0 and 
2.0-2.4, respectively, were used for PCR. 
2.2 Constructs used for transient transfection 
2.2.1 Summary of constructs used for transfection  
 All constructs used, with the exception of pPf86 and pVlh, had their various 
genes cloned into the expression vector pARL1a+ (Crabb et al. 2004). This expression 
vector has been used previously to study the trafficking of STEVOR in the asexual stage 
(Przyborski et al. 2005). 
A               ATGAACATGTATTACGTTAAAATGTTATTGTTTGCCTTTTTAATAAATACATTAGTATTACCACATTATg 
            tatgtaaaaatataaataattattacaataatttaaatatataattaaacaattattgcattttcagtaaa 
tattcattaatcgtctttttcttttttagGAGAATTATCTAAATAACCATTATAATGTATGTCTCATTCAA                
AACAAGACCAAAAGAACAACG 
 
B                ATGAAGATGTATTACCTTAAAATGATATTGTTTAACTTTTTAATTAATACTTTATTATTACCACATTAT 
 
Figure 2.1 Stevor gene fragment sequences in the constructs used for transfections  
A: Stevor gene sequence in transfection construct pSt-I, pSt-I-var, pSt-I-R and pSt-I-var-R, B: Stevor gene 
sequence in transfection constructs PF10_0395 NI FL and PF10_0395 NI FLV, Red: Exon 1, Black, 
lowercase: Intron, Blue: First 69 bp of Exon 2 
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Table 2.2 Constructs used for transient transfection  
Name of 
construct 
Immediately upstream from firefly or renilla 
luciferase gene 
Firefly (FL) or renilla 
(RL) luciferase gene 
Downstream var 
intron present (+) 
Comments 
pPf86 
-1,825 to +10 bp upstream  region from P. 
falciparum hsp86 gene (Pf07_0029) 
FL - 
Kind gift from Dr. Kevin Militello (Militello 
and Wirth 2003)  
Used as the positive control  
Negative FL 1000 bp of firefly luciferase gene FL - 
Negative control plasmid for firefly 
luciferase luminescence (background) 
Negative RL 1000 bp of firefly luciferase gene RL - 
Negative control plasmid for  renilla 
luminescence (background) 
pARL-FL 
Up to ~2600 bp upstream from P. falciparum 
chloroquine resistance transporter (crt) gene 
MAL7P1.27 
FL -  
pARL-RL 
Up to ~2600 bp upstream from P. falciparum 
chloroquine resistance transporter (crt) gene 
MAL7P1.27 
RL -  
pARL-5’3’-
UTR-actin FL 
+1434 bp upstream from P. falciparum actin gene 
PFL 2215 
FL - Courtesy of Zhang Wentao 
pARL-5’-3’-
UTR-actin RL 
+1434 bp upstream from P. falciparum actin gene 
PFL 2215 
RL - Courtesy of Zhang Wentao 
pSt-I 
1000 bp upstream from and the first 233 bp of P. 
falciparum stevor gene PFB1020w 
FL - Courtesy of Yeo Pin Kim 
pSt-I-var 
1000 bp upstream from and the first 233 bp of P. 
falciparum stevor gene PFB1020w 
FL 
+ 
(697 bp PFB 1055c) 
Courtesy of Yeo Pin Kim 
pSt-I-RL 
1000 bp upstream from and the first 233 bp of P. 
falciparum stevor gene PFB1020w 
RL -  
pSt-I-var-RL 
1000 bp upstream from and the first 233 bp of P. 
falciparum stevor gene PFB1020w 
RL 
+ 




1730 bp upstream from and the first 71 bp of P. 
falciparum stevor gene PF10_0395 
FL -  
PF10_0395 NI 
FLV 
1730 bp upstream from and the first 71 bp of P. 
falciparum stevor gene PF10_0395 
FL 
+ 
(697 bp PFB 1055c) 
 
pVlh 
Up to ~2600 bp upstream from Var7b gene from P. 
falciparum Dd2 strain 
FL - 





2.2.2 Plasmid maps of newly-made constructs used in P. falciparum transfection 
experiments 
 
             
 
Figure 2.2 Negative control constructs that were made for transfection into 3D7. (a) Negative control renilla 
luciferase (RL) is promoterless; instead a 1000 bp fragment from the firefly luciferase gene (FL 1000 bp) replaced 
the 5‟-UTR of the P. falciparum 3D7 actin gene. (b) Negative control firefly luciferase (FL) is also promoterless, 
with the same 1000 bp fragment from the firefly luciferase gene replacing the 5‟-UTR of the P. falciparum 3D7 








Figure 2.3 Stevor constructs that had their firefly luciferase gene replaced with the renilla luciferase gene for the 
use in transfection experiments into 3D7. (a) pSt-I-var-RL; pARL backbone with 1000 bp promoter region of 
stevor (PF1020w) with Exon 1, intron and 69 bp of Exon 2; var intron (PFB1055c) replaced PfCam5 (courtesy 






Figure 2.4 New stevor gene constructs PF10_0395 
The stevor gene (PF1020w) as shown in Figure 2.3, was replaced with the complete Exon 1 (69 bp) of  the stevor 
gene PF10_0395 and 1730 bp upstream from its translation start site, both constructs are missing the stevor intron 
and Exon 2 regions. (a) PF10_0395 NI FL V has replaced PfCam5 with the var intron (PFB1055c) (b) PF10_0395 
NI FL still has PfCam5. Restriction enzyme sites are listed in bold. 
 
2.2.3 Cloning procedure 
Primers were designed using OligoPerfect
TM
 Designer available from 
Invitrogen by Life Technologies (tools.invitrogen.com/content.cfm?pageid=9716). All 
primer sequences were optimized to have the highest possible GC percentage, and 
primer lengths were adjusted so that the annealing temperature between primer pairs 
was no larger than 2°C. Annealing temperatures were calculated using the Tm 
calculator available online from Applied Biosystems 
(http://www.appliedbiosystems.com/support/techtools/calc/). Using PlasmoDB, 
Plasmodium genome resource website (http://plasmodb.org/plasmo/) all the sequences 
for the primers used for genomic DNA PCR were blasted against the published P. 
falciparum 3D7 sequence to ensure unique amplification of target insert (Gardner et 
al. 2002). Table 2.3 summarizes all the primers designed for cloning of the six 
constructs listed in section 2.2.2, as well as their Tm‟s. Additional primers that did not 






Table 2.3 Primers used for successful cloning of PF10_0395 NI FL and PF10_0395 NI FL V 
(PF10_0395_F2 and gPF10_0395_R1_NI) and negative control construct FL and RL (FL 200 F and FL 
1000 R). Restriction enzyme sites are underlined. F: forward, R: reverse, FL: firefly luciferase, RL: 
renilla luciferase, NI: no intron (stevor) 
 
Primer name Primer sequence Tm (°C) 
PF10_0395_F2 5' – GGCAGATCTAATGCACTATTTAAGAAAACCTCTCAA – 3' 59.27 
gPF10_0395_R
1_NI 
5' – CCACCTAGGATAATGTGGTAATAATAAAGTATTAATTAAAAAGTTAAAC - 3' 58.62 
FL 200  F 5‟ – GGCAGATCTAGCTATGAAACGATATGGGCT – 3‟  56.46 
FL 1200 R 5‟ – CCACCTAGGCATAATCATAGGACCTCTCACACAC – 3‟ 57.59 
 
PCR amplifications of all the inserts were done as shown in Table 2.4, using 
Kapa HiFi
TM
 DNA Polymerase (KapaBiosystems, USA); set-up was according to the 
manufacturer‟s recommendations. 10 ng of plasmid DNA or 100 ng of 3D7 genomic 
DNA were used with 0.3 µM of each primer, 5 µl of KAPAHiFi Fidelity Buffer with 
MgCl2 (Mg
2+
 2.0 mM), 0.3 mM dNTP and 0.5 U of KAPAHiFi DNA polymerase, 
topped up with distilled water to 25 µl per reaction. PCR products were cleaned using 
Qiaquick PCR Purification Kit (Qiagen, USA).   
 
Table 2.4 PCR reaction conditions used for genomic 3D7 DNA and plasmid DNA  
 
PCR reaction conditions Temperature (°C) Time Number of cycles 
Initial Denaturation 95 2 or 5 min 
         
Denaturation 95 30 seconds 5-6 cycles 
Annealing Tm + 1°C 30 seconds 
 Elongation 68 1 min/kb 
     
 
  
Denaturation 95 30 seconds 24-25 cycles 
Annealing Tm – 1 to 2°C 30 seconds 
 Elongation 68 1 min/kb 
     
 
  






At least 10 µg of vector was digested with the appropriate enzymes for 16 
hours at 37°C. All digested vectors were separated on 0.8% agarose gels and gel 
extracted using QIAquick Gel Extraction kit (Qiagen, Germany), elution with 100 µl 
EB, before being additionally cleaned with QIAquick PCR purification Kit (Qiagen) 
and eluted with 40 µl of EB. Ligation was performed using LigaFast
TM
 Rapid DNA 
Ligation System (Promega) according to manufacturer‟s instructions, with 50-100 ng 
of total digested vector and insert, at an insert to vector ratio of 3:1 and incubated for 
5 to 10 min at room temperature. Depending on the construct either XL10-Gold 
Ultracompetent cells® (Stratagene, USA) or One Shot® Top 10 cells (lab-made stock, 
originally from Invitrogen, USA) were used for transformation. Transformations were 
performed according to manufacturer‟s protocol. 10 µl and 100 µl transformant 
volumes were spread on LB plates with 100 µg/ml of ampicillin and grown for 12-16 
hours at 37°C. Several colonies were chosen and inoculated into 5 ml of LB with 100 
µg/ml of ampicillin at 37 °C for 12-18 hours at 250 rpm. AxyPrepTM Plasmid Mini-
prep kit (Axygen, USA) was used to obtain the plasmid DNA. A restriction digestion 
screen was then performed and the DNA was then run on a 0.8 % agarose gel and 
visualized under UV light. Depending on the construct, some of the positive ones 
were sent for sequencing (1
st
 Base, Singapore) and after correct alignment was 
determined, were used for transfection experiments.  
 Qiagen Plasmid Maxi kit, Endofree Plasmid Maxi kit and Qiagen Plasmid 
Mega kit were all used for purifying plasmid constructs. These kits were used since 
large amounts of plasmid are required for transfection with P. falciparum. All 
constructs used for transfection experiments were re-suspended in 10% sterile TE and 
stored at -20°C.  
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For the cloning of the negative controls, the cloning vectors pARL-5‟UTR 
actin firefly luciferase and pARL-5‟UTR actin renilla luciferase were used to make 
Negative Control FL and Negative Control RL, respectively. The 5‟UTR actin 
(PFL2215w) of 3D7 was removed from both vectors using the restriction enzymes Bgl 
II and Avr II (NEB, USA) and were replaced with a 1000 bp fragment of the firefly 
luciferase gene. Thus both these constructs lack a promoter for the firefly or renilla 
luciferase genes. 
 
2.3  5’RACE experiments on three stevor genes of P. falciparum 3D7 strain 
2.3.1 RNA extractions from cultured P. falciparum 3D7 
RNA was extracted from 1 ml of pelleted 3D7 parasites that were 
predominantly in the late ring to early trophozoite stages. 5 ml of room temperature 
TRIzol (GIBCO, USA) was added to the pelleted parasites and mixed thoroughly in 
15 ml Falcon tubes and subsequently stored at -80°C. Contents were thawed on ice 
and 2 ml of sterile chloroform was added; tubes were then vortexed for 15 sec and 
spun at 11 000 rpm for 15 min at 4°C. 500 µl of the upper aqueous layer was carefully 
removed, taking care to not disturb the solid layer, and aliquoted into 1.5 ml 
microcentrifuge tubes. A 1:10 volume of sterile 3 M sodium acetate was added to help 
precipitation, followed by a 1:1 volume of isopropanol, and then placed overnight at   
-20°C. The tubes were then spun down at 11 000 rpm for 15 min at 4°C. The 
supernatant was removed and the RNA pellet was re-suspended with 75% ethanol 
(chilled to -20°C) and centrifuged at 9000 rpm for 10 min at 4°C. The supernatant was 
removed and the pellet was dried. The pellet was re-suspended in 15 µl of 60°C 
RNAse free water, and all the RNA from the tubes were pooled. The absorbance was 
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measured, 260/280 and 260/230 ratios of ~2.0 and 2.0-2.2, respectively, were used for 
5‟RACE experiments. However, acceptable ratios were not obtained at this point; 
Qiagen‟s RNeasy mini-prep kit needed to be used to clean-up the pooled RNA and 
only then were acceptable ratios obtained. 
2.3.2   5’RACE experiment to determine stevor gene 5’-UTRs of P. 
falciparum 3D7  
The 5‟RACE System for Rapid Amplification of cDNA Ends, Version 2.0 kit 
(Invitrogen, USA) was used to determine the 5‟UTR regions of three stevor genes in 
the 3D7 P. falciparum strain. The following genes were selected for 5‟UTR 
determination: PF10_0395, PFF0850c and PFI0080w as obtained from the 
PlasmoDB, Plasmodium genome resource website (http://plasmodb.org/plasmo). All 
primers were anti-sense and located downstream from each gene‟s intron site. One 
sense primer was designed in the promoter region for each gene to ensure that each set 
of anti-sense primers bound efficiently to 3D7 genomic DNA before performing the 
5‟RACE experiment. The Kapa HiFiTM DNA Polymerase (KapaBiosystems) was used 
for this PCR, and set-up was according to the manufacturer‟s recommendations. Table 
2.5 summarizes the primers used in this experiment. The 5‟RACE experiment was 
conducted according to the manufacturer‟s protocol. For both the dc-tailed cDNA and 
the nested PCR, 2.5U of Platinum Taq DNA polymerase (Invitrogen) was used. The 
PCR conditions of the genomic 3D7, dC-tailed cDNA and the nested PCR are 
outlined in Table 2.4. To analyze the 5‟RACE products 5 µl of each PCR reaction was 
run on a 0.8% agarose gel and visualized under UV light. Several nested PCR 
reactions of the same gene were performed and then pooled in order to have enough 
5‟RACE products for TA cloning. The pooled products of each of the three genes 
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were run on a 2% MetaPhor gel (Lonza, Switzerland) prepared according to the 
manufacturer‟s specifications. Bands no less than 200 bp were excised using Qiagen‟s 
QIAquick Gel Extraction kit before being additionally cleaned with the QIAquick 
PCR purification kit (Qiagen) and eluted with 40 µl of EB. The pGEM
®
 Vector 
System I (Promega) was used for TA cloning and JM109 High Efficiency Competent 
cells (Promega) were used for the transformation. Ligation was performed using 3:1 
and 1:1 insert to vector ratios. Colonies were screened using a pGEM
®
-T vector 
plasmid primer (5‟- GGCCAGTGAATTGTAATACGACTCACTATAGG -3‟) and 
the corresponding GSP 3 primer to ensure positive colony selection. 2.0 U of Taq 
DNA polymerase (Fermentas, Canada), 25 µM MgCl2, and 1.0 µM of each primer 
was added to each PCR reaction, the remaining components were added according to 
the manufacturer‟s specifications. Refer to Table 2.5 for PCR conditions. Positive 
colonies were then sent for sequencing (1
st
 BASE).  
Table 2.5 Touchdown PCR reaction conditions used for genomic 3D7 DNA, for dc-Tailed cDNA, 
nested PCR and bacterial colony screening 
 
Touchdown PCR reaction 
conditions 
Temperature (°C) Time Number of cycles 
Initial Denaturation 94 2 min 
         
Denaturation 94 30 seconds 15 cycles 
Annealing 77-63 (-1 per cycle) 30 seconds 
 Elongation 68 2 min 
     (1 min/kb)   
Denaturation 94 30 seconds 17 cycles 
Annealing 63 30 seconds 
 Elongation 68 2 min 
     (1 min/kb)   







Table 2.6 Primers used for the determination of 5‟UTRs of three stevor genes and genomic 3D7 sense primers
Primer name Base pairs downstream 
from intron 
Primer sequence Tm (°C) 
PF10_0395 GSP 1 211 5‟ – CTTCTTTCAATTGTTTATATGGATCATG -3‟ 58.86 
PF10_0395 GSP 2 125 5‟ – TCTGGATCATTATGATAATGTGGATTATGATTTTGG -3‟ 58.80 
PF10_0395 GSP 3 74 5 – CTTGATTTTATCGTTGTTCCTTGCGTGTTGTTTT – 3‟ 59.31 
PFF0850c  GSP 1 205 5‟ – GCAATTGTTCATATGGTTCATGAA -3‟ 68.33 
PFF0850c  GSP 2 133 5‟ – CTTTGAGTTCTGGATCATTATGATAATGTGGATTATGG – 3‟ 69.36 
PFF0850c  GSP 3 91 5‟ – TGGTTTGTGCTAAGAGTCTTGGTTTTATCGTTG- 3‟ 68.03 
PFI0080w GSP 1 198 5‟ – TTGTGTTTGTGCTAATAATCTTGAATTT -3‟ 70.83 
PFI0080w GSP 2 133 5‟ – CCTTAAGTTCTGGGTCATTATGATAATGTGGATTATG – 3‟ 69.24 
PFI0080w GSP 3 91 5‟ – GTGTTTGTGCTAATAATCTTGAATTTATCGTTGTTCTTTG – 3‟ 69.12 
Sense primer 
gDNA 
Base pairs upstream 
from intron 
Primer sequence Tm (°C) 
gPF10_0395  
Forward 
469 5‟ – TGGTTTACACCCATAACAATTATTGTTATACACATTTATATATGTATTT – 3‟ 67.50 
gPFF0850c  Forward 779 5‟ – GTAACATAAAATAATAGATACAATAGAGAGCATTTTATATGGGTGAA – 3‟ 66.92 















































3.1 Optimization of the transient transfection protocol 
 
 3.1.1 Transient transfections using plasmid constructs with either a firefly or a 
renilla luciferase gene under the control of a chloroquine resistance transporter gene 
promoter of P. falciparum 3D7 
 
The two plasmid constructs: pARL-RL and pARL-FL, made courtesy of Yeo 
Pin Kim, were used to standardize the transfection experiments before using the 
experimental stevor plasmid constructs. pARL-RL consists of a renilla luciferase gene 
immediately downstream from a 1460 bp sequence that is originally found upstream 
from the chloroquine resistance transporter gene of P. falciparum 3D7 (MAL7P1.27). 
pARL-FL is similar, except it has a firefly luciferase gene instead of a renilla 
luciferase gene (Figure 3.1).  
 
 
Figure 3.1 Construct pARL-RL (A) and pARL-FL (B) both sharing the same pARL plasmid backbone  
 
Several rounds of transfection experiments were performed, with none 
yielding a luciferase luminescence reading above the negative controls, which 
consisted of 100 μl of 10% TE.  
3.1.2 Using pARL-5’-3’-UTR-actin-luciferase constructs for transfections  
Following the failed transfection experiments using the plasmid constructs 
pARL-RL and pARL-FL, two newly made constructs, courtesy of Zhang Wentao, 
were used for a subsequent standardization transfection experiment. They were 
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pARL-5‟-3‟-UTR-actin-renilla luciferase and pARL-5‟-3‟-UTR-actin-firefly 
luciferase (Figure 3.2) which were previously shown to work by another researcher in 
the laboratory.  
 
Figure 3.2 The constructs pARL-5‟-3‟-UTR-actin renilla luciferase (A) and pARL-5‟-3‟-UTR-actin 
firefly luciferase (B) both sharing the same pARL plasmid backbone 
 
These experiments were performed to standardize the transfection protocol 
and to determine whether pARL-5‟-3‟-UTR-actin renilla luciferase could act as a 
good internal control for subsequent experiments. As initial experiments separate 
transient transfections with the maximum recommended plasmid DNA amount 
(100µg) were performed using these two constructs in order to determine their 
luminescence reading profile. For both constructs luminescence readings higher than 
the negative controls were recorded (Figure 3.3 and Figure 3.4). Of the two constructs, 
the renilla luciferase construct produced a higher luminescence signal than the firefly 
luciferase construct. The firefly luciferase construct was used as a comparison to the 
















Figure 3.3  Transfection with 100 µg of pARL-5‟-3‟-UTR-actin-renilla luciferase construct; 
synchronization was with a CS SuperMACS column, the wash extract was immediately used for 
sorbitol synchronization. The luciferase assay was performed in the mid-to-late schizont stage. The 















Figure 3.4 Transfection with 100 µg of pARL-5‟-3‟-UTR-actin-firefly luciferase construct; 
synchronization was with a CS SuperMACS column, the wash extract was immediately used for 
sorbitol synchronization. The luciferase assay was performed in the mid-to-late schizont stage. The 





For all set-ups of transient transfections the SuperMACS synchronization technique 
was validated by making a slide of both the wash, consisting of the rings and early-to-
mid-trophozoites, and the extract, consisting of late trophozoites to early-to-mid 
schizonts, as the presence of the correct stages was noted (Figure 3.5). After every 
synchronization with 5% sorbitol, a slide was also made to check whether the 
synchronization was effective, as the presence of mostly ring stage parasites was 
noted. Thus this ensured that after the subsequent invasion the parasite population 
would be healthy and very synchronized, ensuring good transfection efficiency. Good 
transfection efficiency makes certain that the best possible luciferase signal is 




Figure 3.5 Example of a schizont extract after passing the parasite culture through a CS SuperMACS 
column. 
 
For the next transfection a 1:1 ratio of pARL-5‟-3‟-UTR-actin-firefly 
luciferase to pARL-5‟-3‟-UTR-actin renilla luciferase was used (50 µg of each 
construct), 100 μl of 10% TE was used as the negative control, and 100 µg of pPf86 
was used as the positive control and they were all in triplicate. This experiment was 
performed to practice co-transfection technique and to confirm that pARL-5‟-3‟-UTR-
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actin renilla is indeed a good internal control due to the fact that it produces a high 
luminescence reading as previously shown (Figure 3.3). The overall goal of this 
experiment was to further standardize the transient transfection experimental set-up. 
The transfection worked, as the positive control pPf86 worked well, with 
luminescence readings above 55 000 LU (Figure 3.6 C). The luminescence readings of 
the three pARL-5‟-3‟-UTR-actin-firefly luciferase : pARL-5‟-3‟-UTR-actin renilla 
luciferase experimental repeats had a large standard deviation as shown in Figure 
3.6A, namely SD = 2088.50. However once one of the experimental results was 
removed the standard deviation was much smaller for the remaining two (Figure 
3.6B). This shows the actual variation possible within experimental samples, thus this 
is why the average of the ratios of the firefly : renilla luminescence readings are meant 
to be used; since as Figure 3.6 D shows, the average of the ratios of all three pARL-
5‟-3‟-UTR-actin firefly luciferase : pARL-5‟-3‟-UTR-actin renilla luciferase repeats 
has a very small standard deviation (SD = 759.50). From this experiment it was 
decided that pARL-5‟-3‟-UTR-actin renilla luciferase construct would be co-
transfected with all the firefly luciferase reporter constructs for nearly all subsequent 
transfection experiments in order to take into account this variation among samples. 
Thus it acted as an internal control in these experiments. 
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Figure 3.6 Transfection of  50 µg of pARL-5‟-3‟-UTR-actin-firefly luciferase together with 50 µg of pARL-5‟-3‟-UTR-actin-renilla luciferase, 100µg pPf86 positive control construct 
and 100 µl of  10% TE in P. falciparum 3D7 strain. Synchronization was with a CS SuperMACS column; the wash extract was used immediately for sorbitol synchronization. The 
luciferase assay was performed in the mid-to-late schizont stage. The experiment was performed in triplicate. A)Triplicate results for both pARL-5‟-3‟UTR-actin luciferase constructs, 
B) Removal of the experimental sample with a lower luminescent reading, pARL-5‟-3‟UTR-actin luciferase constructs in duplicate, C) pPf86 positive control, D) Average of the 
ratios of firefly/renilla luminescence readings for all three experimental samples as well as the negative control samples. LAR II reagent is used to determine firefly luminescence 
readings and Stop & Glow reagent is used to determine  renilla luminescence readings.
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3.2 Transfection with stevor constructs  
 
3.2.1 Stevor constructs pSt-I and pSt-I-var intron 
 
These two constructs were used to try to determine the role of the stevor intron 
as well as the var intron in the transcriptional control of stevor gene expression. The 
incomplete stevor gene PFB1020w of P. falciparum 3D7 was used for the initial 
experimental transient transfections. Two versions of the construct were used, one 
without a var intron and one with a var intron, namely pSt-I and pSt-I var intron, 
respectively (Figure 3.7).  
 
Figure 3.7 Stevor constructs pSt-I (A), pSt-I var (B), pSt-I-R (C) and pSt-I-R var (D), they all have the 
same pARL backbone 
 
They were co-transfected with pARL-5‟-3‟-UTR-actin-renilla luciferase 
constructs at three different ratios (total 100 µg each time), namely: 50:50, 75:25, and 
87.5:12.5, respectively. These three ratios were chosen to determine which resulted in 
good luminescence signals of both the stevor constructs and the internal control 
construct. Of the three attempted transient transfections only two were successful with 
these constructs. In the first experiment, as shown in Figure 3.9, very low 
luminescence signals for both stevor constructs was observed yet the pARL-5‟-3‟-
UTR-actin-renilla luciferase constructs added to each stevor gene construct did result 







deemed to be very low as it was almost the same as the negative control which 
consisted of 10% TE. Whether it was an actual low luminescence signal, or if it was 
just background was difficult to determine. In the second transfection, Figure 3.11, 
again very low firefly luminescence signals were detected for both stevor constructs 
and again the pARL-5‟-3‟-UTR-actin renilla luciferase transfected constructs did 
result in a good renilla luminescence signal (much higher than the negative control). 
Here the positive control pPf86 also showed a high firefly luminescence signal, 
indicating that the transfection worked. Furthermore, in this experiment the values of 
renilla luminescence corresponded much better with the amount of the renilla 
construct added to each stevor gene construct sample (50 μg or 25 μg or 12.5 μg). The 
standard deviation was high in all samples (Figure 3.9 and Figure 3.11) and the 
average ratios of firefly/renilla luminescence between these two repeat experiments 
were not at all similar (Figure 3.10 and Figure 3.12). As a result no conclusion for the 
role of both the stevor intron or the var intron in the transcriptional control of stevor 
gene expression could be drawn from these two stevor constructs. A new apporach 
was needed. 
Since it was observed in the first transfection experiment using the two stevor 
constructs resulted in a firefly luminescence signal that was very low, i.e. they were 
not much higher than the 10% TE negative control, it was decided that two negative 
control constructs should be made to ensure that it was not the DNA itself that was 
causing the slightly higher luminescence signal observed in the two stevor construct 
samples when comparing them with the negative control samples.  
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Thus in the second transfection using these two stevor constructs, the construct 
Negative control FL was used (Figure 3.8 B). The Negative control RL (Figure 3.8 A) 
was not yet made when this experiment was performed. 
 
 
Figure 3.8 Newly made negative control constructs Negative control RL (A) and Negative control FL 
(B) (each share the same backbone of pARL) 
 
Negative control constructs for firefly luciferase and renilla luciferase genes 
were made successfully, as shown in Figure 3.13 and Figure 3.14, respectively. The 
1000 bp firefly luciferase gene fragment was correctly inserted into both reporter 














pSt-I var intron /pARL-5'-3'-UTR-
actin-renilla luciferase  50:50
pSt-I/pARL-5'-3'-UTR-actin-renilla 
luciferase  75:25
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Figure 3.9 Transfection with the stevor gene PFB1020w of P. falciparum 3D7, with and without a downstream var intron: pSt-I and pSt-I var intron, respectively. Three 
different ratios of either pSt-I or pSt-I var intron constructs co-transfected with pARL-5‟-3‟-UTR-actin-renilla luciferase construct were used for a total of 100 µg plasmid 
DNA in each sample: 50:50, 75:25, 87.5:12.5, respectively. Synchronization was with a CS SuperMACS column, the wash extract was immediately used for sorbitol 
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Figure 3.10 Average firefly/renilla ratios of 50:50, 75:25, 87.5:12.5 of both pSt-I/pARL-5‟-3‟-UTR-actin renilla luciferase and pSt-I var intron/pARL-5‟-3‟-UTR-actin renilla 





























pSt-I var intron /pARL-5'-3'-UTR-
actin-firefly luciferase  50:50
pSt-I/pARL-5'-3'-UTR-actin-renilla 
luciferase  75:25
pSt-I var intron /pARL-5'-3'-UTR-
actin-renilla luciferase  75:25
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luciferase  87.5: 12.5
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Figure 3.11 Repeat of the transfection with the stevor gene PFB1020w of P. falciparum 3D7, with and without a downstream var intron: pSt-I and pSt-I var intron, 
respectively. (A) 100 µg of pPf86 used as the positive control, (B) Three different ratios of either pSt-I or pSt-I var intron constructs co-transfected with pARL-5‟-3‟-UTR-
actin renilla luciferase were used for a  total of 100 µg of plasmid DNA in each sample: 50:50, 75:25, 87.5:12.5, respectively. Synchronization was with a CS SuperMACS 
column. The wash extract was used immediately for sorbitol synchronization, and the luciferase assay was performed in the mid-to-late schizont stage. 100 µg of Negative 
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Figure 3.12 Average firefly/renilla ratios of 50:50, 75:25, 87.5:12.5 of both pSt-I/pARL-5-‟3‟-UTR-actin renilla luciferase and pSt-I var intron/pARL-5‟-3‟-UTR-actin renilla 




Figure 3.13 Restriction enzyme digestion of Negative control firefly luciferase (FL) plasmids extracted 
from five positive colonies with Avr II and Bgl II. The small fragment showed the correct size of 1000 
bp, indicating the 1000 bp firefly luciferase gene fragment insertion. 0.8% agarose gel with ethidium 
bromide at 100 V for 50 min, Fermantas O‟GeneRulerTM 1 kb DNA ladder, ready-to-use, 250-10,000 






Figure 3.14 Restriction enzyme digestion of Negative control renilla luciferase (RL) plasmids extracted 
from five positive colonies with Avr II and Bgl II. The small fragment showed the correct size of 1000 
bp, indicating the 1000 bp firefly luciferase gene fragment insertion (Lanes 1-5). Restriction enzyme 
digestion of the same constructs with Avr II and Kpn I, the small fragment showed the correct size of 
936 bp, indicating that it is indeed the renilla luciferase gene in these constructs (Lanes 6-10). 0.8% 
agarose gel with ethidium bromide at 100 sV for 50 min. Fermantas O‟GeneRulerTM 1 kb DNA ladder, 
ready-to-use, 250-10,000 bp was used as the DNA marker. 
 
As the low stevor signals were observed in these two transient transfections, and only 
a maximum of 87.5 μg of each stevor construct was used, an experiment using the 
maximum recommended amount of plasmid DNA (100 μg) was performed. It was 
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compared with pVlh, a construct with a firefly luciferase gene under the control of a 
var promoter. This construct was chosen as a comparison with one of the stevor 
construct (pSt-I) since it was used by other research groups, thus was known to work 
and the promoter was also from one of the other multi-gene families of P. falciparum, 
thus there was a hope that it might give an idea of what sort of firefly luminescence 












Figure 3.15 Transfection with 100 µg of pSt-I and 100 µg of pVlh, in duplicate, 
single pPf86 positive control (LU = 14 094). 
 
Transfection with 100 µg of both pSt-I and pVlh was performed, firefly 
luminescence was not significantly higher than the negative control luminescence 
seen in previous experiments for firefly luciferase luminescence signals. The 
transfection worked as the pPf86 positive control was 14,094 (data not shown) 
(Figure 3.15).  
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Due to low luminescence values for the stevor gene constructs the firefly 
luciferase gene in pSt-I and pSt-I var intron was removed and replaced with the renilla 
luciferase gene and both became known as pSt-I-RL and pSt-I-var RL (Figure 3.7 C 
and D, respectively), with „var‟ representing a var intron located downstream from the 
renilla luciferase gene (Figure 3.16). A transfection experiment was performed, but 
the renilla luminescence values with these new constructs were the same as those for 
the negative renilla control. The positive control, pPf86, worked well, with an average 
firefly  luminescence value of 22476 and a SD of 4098.50.  
 
Figure 3.16 pSt-I-RL and pSt-I-var-RL positive colony purified plasmid constructs. Three colonies and 
four colonies of pSt-I-var-RL and pSt-I-RL were restriction enzyme digested, respectively. Avr II and 
Kpn I digestion was used to confirm presence of 936 bp renilla luciferase gene. EcoRV and BamH1 
digestion was used to confirm presence of the var intron (697 bp) or PfCam5 (850 bp). Lanes 1-3: pSt-
I-var-RL digested with Avr II and Kpn I, Lanes 4-6: pSt-I-var-RL digested with EcoRV and BamH1, 
Lanes 7-10: pSt-I-RL digested with Avr II and Kpn I, Lanes 11-14: pSt-I-RL digested with EcoRV and 
BamH1. pSt: PFB1020w stevor gene (Exon 1, intron and 69 bp Exon 2) with 1000 bp upstream of ATG 
site, I: stevor intron, RL: renilla luciferase, var: a var gene intron (PFB1055c). 0.8% agarose gel with 
ethidium bromide at 100V for 50 min. Fermantas O‟GeneRulerTM 1 kb DNA ladder, ready-to-use, 250-
10,000 bp was used as the DNA marker. 
 
3.2.2 A new approach: cloning and transfection with two constructs of the 
stevor gene PF10_0395 
 
 As the two stevor constructs (pSt-I and pSt-I var intron) resulted in a low 
luminescence signal, even when troubleshooting experiments were performed, namely 
when the maximum amount of one of the constructs, pSt-I, was transfected and after 
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the firefly luciferase gene was replaced with the renilla luciferase gene in both 
constructs, a new approach was deemed appropriate.  
Only two constructs with an alternative stevor gene (PF10_0395) and a large 
upstream region were successfully cloned and used for transient transfections (Figure 
3.17). Both have the same 1800 bp upstream sequence and they do not include any 
base pairs downstream from the end of Exon 1, thus no stevor gene intron. However 
one of these constructs includes a var gene intron located downstream from the firefly 
luciferase gene. Both constructs were sequenced at the beginning of the promoter (of 
the insert) and all of the stevor Exon 1 was sequenced. No mutations were found in 
either constructs‟ Exon 1 segment. No clones were obtained from the other two 
alternative stevor genes, PFF0850c and PFI0080w. Due to the difficulty encountered 
while cloning these constructs, optimization experiments were performed, namely 
new stocks of Bgl II and Avr II were used to re-digest the inserts and the backbones 




Figure 3.17 Positive colonies that resulted from the cloning of PF10_0395 stevor gene and its upstream 
region. Lane 1: PF10_0395 NI FL, Lane 2: PF10_0395 NI FL V, expected size of insert 1800 bp. NI: 
no intron (stevor), FL: firefly luciferase gene, V: var intron. 0.8% agarose gel with ethidium bromide at 
100V for 50 min. Fermantas O‟GeneRulerTM 1 kb DNA ladder, ready-to-use, 250-10,000 bp was used 




Figure 3.18 Constructs PF10_0395 NI FL and PF10_0395 NI FLV (both share the same backbone of 
pARL) 
 
Transient transfections into 3D7 P. falciparum using 50 µg of PF10_0395 NI FL and 
50 µg of PF10_0395 NI FLV were performed. All transient transfections with these 
two constructs were co-transfected with 50 µg of pARL-5‟-3‟-UTR-actin-renilla 
luciferase construct. The first two transient transfections with these constructs were 
unsuccessful, as none of the constructs resulted in reporter signals above the negative 
controls, including the positive control pPf86. Two troubleshooting transient 
transfections were then performed. The first determined that it was not the Dual-
Luciferase Reporter Assay System kit that was faulty, as it was compared with the kit 
used in Dr. Zybnek Bozdech‟s laboratory that was known to work well. The positive 
control pPf86 was used in this experiment, and although the luminescence signal was 
low, values of approximately 1000 luminescence units (LUs) were recorded for both 
kits. The second troubleshooting experiment determined that it was not the cytomix or 
the type of plasmid purification kit that was responsible for the failed transfections. 
Cytomix from Dr. Zbynek Bozdech laboratory and cytomix that was prepared in May 
2010 by me, and used in all the transient transfection experiments to date, were used 
for comparison. The two kits used to purify two separate stocks of pPf86 plasmid 
were Qiagen Plasmid Maxi kit and Qiagen Plasmid Mega kit. In this experiment the 
luminescence values were very high in all samples, regardless of the cytomix used or 
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the positive control construct plasmid purification kit used (Figure 3.19). However, 
what was different in this transfection was that it was performed during the very early 
ring stage (less than 6 hours post-invasion), unlike in previous transfections, which 










Cytomix 1 50:50 pPf86 B :pARL-
5'3'UTR actin Renilla 





Figure 3.19 Troubleshooting of transient transfection experiments: ruling out cytomix and positive 
control pPf86 construct; Cytomix A from Dr. Zybnek Bozdech‟s laboratory, Cytomix B prepared by 
me, pPf86 A: Qiagen Endofree Maxi kit, August 2010; pPf86 B: Qiagen Endofree Mega kit, November 
2010, performed in duplicate, synchronization using one CS SuperMACS column, extract used and then 
sorbitol synchronization performed 10-18 hours after re-invasion. Blue: LAR II used for firefly 
luciferase activity and Red: Stop and Glow reagent used for renilla luciferase luminescence. 
 
After these troubleshooting experiments and the realization that transfections 
should be performed only up to six hours post-invasion, PF10_0395 NI FL and 
PF10_0395 NI FLV were transiently transfected into 3D7 P. falciparum again, this 
time at the very early ring stage (>6 hours post-invasion), Figure 3.20 and Figure 3.22. 












50:50 pPf86  : pARL-5'3'UTR actin renilla 50:50 PF10_0395 NI FLV : pARL-5'3'UTR 
actin renilla 
50:50 PF10_0395 NI FL : pARL-5'3'UTR 
actin renilla 





Figure 3.20 Transfection of PF10_0395 NI FL and PF10_0395 NI FLV. Total of 100 µg of plasmid 
DNA in each sample, 50 µg : 50 µg of either stevor construct or positive control pPf86 with pARL-5‟-
3‟-UTR-actin-renilla luciferase, the negative control was 50 µg : 50 µg of Negative control FL and 
Negative control RL, respectively. Synchronization using one CS SuperMACS column, extract used 
and then sorbitol synchronization performed 10-18 hours after re-invasion. Luciferase assay in mid-to-
late schizont stage. All were in duplicate. Blue: LAR II used for firefly luciferase activity and Red: Stop 
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Figure 3.21 Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-5‟-3‟UTR renilla luciferase, 
PF10_0395 NI FL/pARL-5‟-3‟UTR renilla luciferase, positive control pPf86/ pARL-5‟3‟UTR renilla 
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Figure 3.22 Repetition of transfection of PF10_0395 NI FL and PF10_0395 NI FLV. Total of 100 µg 
of plasmid DNA in each sample, 50 µg : 50 µg of either stevor construct or positive control pPf86 with 
pARL-5‟-3‟-UTR-actin-renilla luciferase, the negative control was 50 µg : 50 µg of Negative control 
FL and Negative control RL, respectively. Synchronization using one CS SuperMACS column, extract 
used and then sorbitol synchronization performed 10-18 hours after re-invasion. Luciferase assay at 
mid-to-late schizont stage. All were in duplicate. Blue: LAR II used for firefly luciferase activity and 
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Figure 3.23 Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-5‟3‟UTR renilla luciferase, 
PF10_0395 NI FL/pARL-5‟-3‟UTR renilla luciferase, positive control pPf86/ pARL-5‟-3‟UTR renilla 




 Subsequently two transient transfections were performed with the same 
constructs and amounts (µg), however, after electroporation the contents were split 
into two flasks, and this allowed two luciferase assays to be able to be performed. One 
was again at the mid-to-late schizont stage and the other one was after re-invasion, 
namely in the late trophozoite to early schizont stage; that is after the S-phase. Only 
the first experiment was successful, as shown in Figure 3.24, where the luciferase 
units are shown, and in Figure 3.25, where the average of the ratios of firefly/renilla 
luciferase signals is presented. The positive control pPf86 showed good expression 
and the standard deviations were small for all co-transfected construct samples. Figure 
3.25 shows that the average ratios of firefly/renilla luminescence with the two 
different stevor constructs, PF10_0395 NI FLV and PF10_0395 NI FL remained 
almost unchanged after re-invasion. Furthermore, in all luciferase assays performed in 
the early schizont stage with these two stevor constructs the luciferase units (Figure 
3.20, Figure 3.22, Figure 3.24 A and Figure 3.26) were all similar, and the average of 
the ratios of firefly/renilla figures demonstrates this again (Figure 3.21, Figure 3.23, 
Figure 3.25 A and Figure 3.27). In the attempted repeat of the re-invasion experiment 
only the first luciferase assay was successful due to the fact that there was no reporter 
signal above the negative control background readings for any of the experimental 
samples in the re-invasion luciferase assay (data not shown). Refer to Appendix A for 
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Figure 3.24 Re-invasion transfection of PF10_0395 NI FL and PF10_0395 NI FLV. A: Luciferase 
assay performed at mid-to-late schizont stage. B: Luciferase assay performed at late trophozoite to early 
schizont stage. Total of 100 µg of plasmid DNA in each sample, 50 µg : 50 µg of either stevor 
construct or positive control pPf86 with pARL-5‟-3‟-UTR-actin-renilla luciferase, the negative control 
was 50 µg : 50 µg of Negative control FL and Negative control RL, respectively. Synchronization using 
one CS SuperMACS column, extract used and then sorbitol synchronization performed 10-18 hours 
after re-invasion. All were in duplicate. Blue: LAR II used for firefly luciferase activity and Red: Stop 
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Figure 3.25 Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-5‟-3‟UTR renilla luciferase, 
PF10_0395 NI FL/pARL-5‟-3‟UTR renilla luciferase, positive control pPf86/ pARL-5‟-3‟UTR renilla 
luciferase and pARL-FL negative control/pARL-RL negative control. (A) Before re-invasion, data 
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Figure 3.26 Attempted repetition of re-invasion transfection PF10_0395 NI FL and PF10_0395 NI 
FLV. Total of 100 µg of plasmid DNA in each sample, 50 µg : 50 µg of either stevor construct or 
positive control pPf86 with pARL-5‟-3‟-UTR-actin-renilla luciferase, the negative control was 50 µg : 
50 µg of Negative control FL and Negative control RL, respectively. Synchronization using one CS 
SuperMACS column, extract used and then sorbitol synchronization performed 10-18 hours after re-
invasion. Luciferase assay performed in the mid-to-late schizont stage. All were in duplicate. Blue: 
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Figure 3.27 Average firefly/renilla ratios of PF10_0395 NI FLV/pARL-5‟3‟UTR renilla luciferase, 
PF10_0395 NI FL/pARL-5‟3‟UTR renilla luciferase, positive control pPf86/ pARL-5‟3‟UTR renilla 
luciferase and pARL-FL negative control/pARL-RL negative control, data refers to Figure 3.26.95 





3.3 Stevor gene 5’UTRs from 5’RACE experiment 
 
As the transcriptional start sites of the stevor multi-gene family are not known, 
three stevor genes of P. falciparum 3D7 were selected for 5‟RACE experiments. 
Three sets of primers were designed for 5‟RACE experiments of the stevor genes 
PF10_0395, PFF0850c and PFI0080w. GSP1 was used for the reverse transcriptase 
experiments, GSP2 was used for the dc-tailed cDNA PCR and GSP3 was used for the 
nested PCR. All three sets of primers were first tested in a PCR reaction using 
genomic 3D7 DNA to assess their ability to bind to the correct sequence (Figure 3.28). 
All primers bound to the 3D7 genomic DNA (data for GSP1 not shown). 
Results from the dc-tailed cDNA PCR and nested PCR are shown in Figure 
3.29. Following gel extraction and TA cloning 18 positive colonies were screened by 
PCR with the respective gene-specific 3 (GSP3) primer and pGEM-T vector plasmid 
primer, mini-preps were performed on all colonies that showed a band and sent for 
sequencing.  
PF10_0395 resulted in 11 positive colonies, PFF0850c had three positive 
colonies and PFI0080w had nine positive colonies. Based on sequencing results 
however none of the 23 positive colonies had inserts that included any regions 
upstream of the ATG site of any of the three stevor genes. Only one positive colony 
had an insert that originated from RNA, as there was no intron present and both Exon 
1 and Exon 2 sequences were found adjacent to one another, it was for PFF0850c. The 
remainder either had inserts that were only of Exon 2, or the insert had some or all of 
the respective gene‟s intron, indicating that there was some genomic DNA still present 





Figure 3.28 Control for primers GSP2 and GSP3 used for the dc-tailed cDNA PCR and nested PCR, 
respectively. Lane 1-2: PF10_0395, GSP 2 and GSP3, respectively. Lane 3-4: PFF0850c, GSP 2 and 
GSP 3, respectively, Lane 5-6: PFI0080w, GSP 2 and GSP 3, respectively, Lane 7 positive control, size 
correct. 0.8% agarose gel with ethidium bromide at 100V for 50 min. Fermantas O‟GeneRulerTM 1 kb 




Figure 3.29 5‟RACE PCR of dc-tailed cDNA and nested PCR of three stevor genes, Lane 1: 
PF10_0395 dc-tailed cDNA using GSP2 and AAP primers, Lane 2: PF10_0395 nested PCR using 
GSP3 and AUAP primer, Lane 3: PFF0850c dc-tailed cDNA using GSP2 and AAP primers, Lane 4: 
PFF0850c nested PCR using GSP3 and AUAP, Lane 5: PFI0080w dc-tailed cDNA using GSP2 and 
AAP primers, Lane 6: PFI0080w nested PCR using GSP3 and AUAP primers.0.8% agarose gel with 
ethidium bromide at 100V for 50 min. Fermantas O‟GeneRulerTM 1 kb DNA ladder, ready-to-use, 250-




























































Chapter 4: Discussion 
 
For the efficient silencing of var genes, it was found in earlier studies that a 
proximal promoter was required, namely the var intron (Deitsch et al. 2001). One aim 
in this study was to determine the role of the stevor intron in stevor transcriptional 
control, and whether it could silence stevor gene expression. Members of the var and 
stevor families tend to cluster together in the genome of P. falciparum suggesting that 
co-regulation of the two families is possible via mechanisms that take advantage of 
their close proximity. However, analysis of the transcriptional profiles of both families 
before and after selection in trophozoite-stage parasites did not support this, as the 
transcriptional profile only changed for the var gene family after selection (Sharp et 
al. 2006). The second aim in this study was to determine if a selected var intron had 
any ability to control stevor gene transcription. The transcriptional start sites have 
been determined in a range of P. falciparum genes and gene families, including the 
var and rif multi-gene families (Horrocks et al. 2009). The third aim was to determine 
the length of the 5‟UTRs of three stevor genes using the 5‟RACE technique. 
Unfortunately many difficulties were encountered while trying to achieve these goals. 
To begin with, problems were encountered while cloning the three 3D7 stevor 
genes into the designated reporter constructs. Primers were designed to be at least 
1400 bp upstream from each of the three selected stevor genes‟ ATG start sites, and 
two forms of insert were to be cloned, one without the stevor intron and the other with 
it and connected to a short fragment of Exon 2. These inserts were then supposed to 
be cloned into four different reporter constructs, which either had a downstream 
firefly luciferase gene or a downstream renilla luciferase gene, and either a (further) 
downstream var intron or PfCam5‟ promoter. However, as mentioned only two inserts 
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were successfully cloned into two different reporter constructs. Reasons why the other 
constructs were not successfully cloned may be due to the fact that P. falciparum 
intergenic regions are often over 90% A+T-rich and are generally composed of highly 
repetitive sequences or long homopolymorphic adenosine and thymidine (poly 
(dA)poly(dT)) tracts (Polson et al. 2005). A+T-rich sequences are known to be very 
unstable and all these constructs had large (>1.4kb) upstream sequences. There were 
many more colonies on the vector-insert ligated plates than on the vector-only ligated 
plates, and after restriction enzyme screening, most mini-prep purified plasmids 
resulted in two bands, of which the smaller of the two was too large to be the desired 
insert. As the PCR of all inserts was successful, the difficulties must have arisen in the 
restriction enzyme digestion of the vector or the insert, or both, furthermore it may 
have also arisen in the ligation or the transformation steps of the cloning procedure. 
De-phosphorylation with alkaline phosphatase, calf intestinal, of the reporter vectors 
was not performed and it was only in later stages that the idea of performing this step 
was considered, though time restrictions did not permit following this course of action 
and thus perhaps it could be done to increase the specificity of ligation to the insert in 
future work. Also, during the ligation there may have been some re-arrangements in 
the region upstream of the ATG start site, resulting in these observed larger than 
expected inserts. Following ligation, plasmid super-coiling can also favour secondary 
structures that cause rearrangements or deletions, especially in the upstream segment 
(USS). Different ligation ratios could have been used as well.  
Transient transfection of reporter gene constructs has been used for years to 
investigate gene expression in these parasites; and for the most part have focused on 
some element of control mediated at the level of transcriptional initiation and post-
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transcriptional regulation (Horrocks et al. 2009). The first transient transfection 
experiments performed in this study used pARL-FL and pARL-RL reporter 
constructs. They were intended to standardize the experiment procedure, but all 
transfections with them were unsuccessful. Several changes were made to try to find a 
successful method. First, synchronization was performed by fractionation on a Percoll 
gradient followed by sorbitol lysis once re-invasion occurred. However, the Percoll 
seemed to have a detrimental effect on parasite health, to the point where it was 
decided that for these transient transfections, it would be better to use CS 
SuperMACS columns. These columns use magnetic forces to separate the early-to-
mid schizont stages from all other stages, since there is enough accumulation of the 
insoluble magnetic crystal known as hemozoin in the food vacuole of the parasite. 
This results in these blood stage-specific parasites being able to stay in the column, 
while the other parasite blood stages are washed through it (Parroche et al. 2007). 
Once the switch to CS SuperMACS was made, transfection experiments were still 
unsuccessful. 
However, two newly made constructs, courtesy of Zhang Wentao, following 
her successful transient transfections in the laboratory, were used to standardize the 
transfections. These constructs shared a promoter region of the P. falciparum actin 
gene (PFL2215w), which is expressed throughout the whole blood-stage of the 
parasite. Following these successful transfections it was decided that the construct 
with the renilla gene that had an actin promoter region both upstream and downstream 
of it, would be used as the internal control in all subsequent experiments. Thus the 
experimental stevor reporter constructs were then used for transfections, courtesy of 
Yeo Pin Kim. Unfortunately, none of these constructs resulted in luminescence 
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readings above the negative control that is the background luminescence. 
Furthermore, the two „successful‟ experiments with these constructs showed a large 
standard deviation both internally, among different ratios, and between one another. 
Also, the average ratios of firefly/renilla luminescence from both experiments were 
not at all similar. No conclusions were able to be made. Troubleshooting experiments 
were then performed. To eliminate the possibility that the low luminescence signals 
observed with these two stevor constructs was not due to the fact that only a 
maximum of 87.5 µg was added, the maximum recommended amount of 100 µg of 
one of the stevor plasmid DNA constructs was transfected and compared with a 
construct that had a firefly luciferase gene under the control of a var gene promoter 
(pVlh), which is known to work, as shown by Deitsch and colleagues (1999). 
Unfortunately, the absolute firefly luminescence readings from this stevor construct 
was not much higher than the previous background readings. But this transfection was 
deemed successful, as the positive control, pPf86, showed good expression. 
The two negative control constructs, both lacking a promoter, were made to 
ensure that there was no significant absolute firefly or renilla luminescence difference 
between parasites transfected with or without DNA, and no such difference was noted. 
As the luminescence readings were much higher for renilla luciferase, it was 
decided that perhaps adding a renilla luciferase gene downstream from the stevor gene 
and its promoter would result in higher absolute luminescence readings as well. 
Unfortunately, this was not the case, as the positive control worked well, but there was 
no luminescence reading from either constructs. The USS of this stevor gene is 1000 
bp in length; however it is possible that the 5‟UTR in this particular stevor gene is 
longer than that, resulting in its inability to be properly translated. In fact, it appears 
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that 5‟UTRs of P. falciparum appear to be long when compared to other eukaryotes 
(Horrocks et al. 2009).  
Based on the results from the study by Sharp and colleagues (2006), who 
found three stevor genes to be the dominant transcripts in gametocytes, namely 
PF10_0395, PFF0850c and PFD0065w, which were also present in trophozoites, 
along with another stevor gene, PFI0080w, which accounted for approximately 20% 
of stevor in this trophozoite transcript pool, thus as the predominant transcripts that 
were found in these two blood stages, it was decided that the genes PF10_0395, 
PFF0850c and PFI0080w would be used for subsequent transfection experiments. The 
new constructs with these three different stevor genes would be cloned into the same 
vectors as the previous stevor gene after it had been removed. After several tries, two 
such constructs were made, both were PF10_0395, and both only had Exon 1, but one 
lacked the downstream var intron. 
Three subsequent transient transfections with these two constructs were not 
successful. Troubleshooting transient transfections were thus performed, using the 
positive control vector pPf86, and following the elimination of several factors not 
responsible for the transfection failures, including the kit, the cytomix and the plasmid 
purification kit, it was eventually determined that the transfection should only be 
performed in the very early ring stage, as the erythrocyte membrane is not too rigid 
and more likely to be stable following electroporation; as it has been generally 
accepted that in P. falciparum mature blood stage forms drastically increase the 
erythrocyte rigidity (Scherf et al. 2008). Most previous transient transfection 
experiments had been performed between 6-10 hours post-invasion, but with this new 
information, transfections are only to be performed at no more than 6 hours post 
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invasion to ensure the highest transfection efficiency possible and thus successful 
transfections.  
Transient transfections with these two stevor constructs were then successful, 
as shown with the high expression of the positive control, pPf86. Furthermore, the 
reliability of these transfections was shown, since several repetitions of the luciferase 
assays performed before re-invasion in the same stage, namely the early schizont 
stage, showed consistent results, as shown in the average ratios of firefly/renilla 
luminescence and the small standard deviation. The absolute readings of renilla 
luminescence were the same relative to the absolute readings of firefly luminescence 
between these experiments, indicating that renilla is a good internal control and 
demonstrates good transfection technique. In the only successful re-invasion 
transfection experiment, it appears that there was no relative decrease in expression of 
either PF10_0395 constructs, as the overall proportion of the luminescence was the 
same in both assays and the average ratio of firefly/renilla luminescence remained 
constant and the standard deviation was small for all samples. Although this is only 
one experiment, it is possible that based on this experiment the var intron does not 
have an effect on the regulation of stevor transcription as there was no change in the 
averages of the ratios of firefly/renilla luminescence before and after invasion, i.e. 
after the S-phase. Clearly, this transfection needs to be repeated to confirm this 
analysis.  
The same three stevor genes, PF10_0395, PFF0850c and PFI0080w, that were 
used for cloning and eventual transient transfection experiments (PF10_0395 only), 
were chosen for 5‟RACE experiments for the same reason, that is to say they were 
found to be the predominant stevor genes expressed in P. falciparum as determined by 
76 
 
Sharp and colleagues (2008). Due to the limited information on stevor gene 
expression, this was deemed to be the best approach. Many problems were 
encountered during the 5‟RACE experiment performed to determine the 5‟ UTR 
region of the three stevor genes. First, the purity of the RNA after extraction from the 
parasite was unsatisfactory; only after the extraction was cleaned-up again using 
Qiagen‟s RNeasy mini kit was it deemed acceptable for reverse transcriptase 
experiments. Based on sequencing results of the 23 positive clones only one was 
originally based on RNA, as it lacked an intron sequence but included both the Exon 1 
and Exon 2 sequences adjacent to one another. None of the clones included any 
regions upstream from their ATG start site; they were either fragments of Exon 2, or 
fragments of Exon 2 and some of the intron, or fragments of Exon 1, the intron, and 
Exon 2. DNase I digestion of the RNA preparation was not performed, as it was not 
suggested in the main protocol; and in retrospect could have been performed to 
increase the chances of isolating cDNA. Following the nested PCR, using GSP3 
primers, there was no clear band seen in any of the three stevor genes, which might be 
due to the fact that the vast majority of P. falciparum genes also contain multiple 
initiation sites, often over a large area of sequence, and thus different 5‟UTR lengths 
would be expected. This may be attributable to the prevalence of large AT stretches in 
their upstream regions (Coleman and Duraisingh 2008). In one study of full-length 
parasite cDNAs generated by the oligo-capping method, it was shown that nearly 
every gene studied underwent promiscuous transcription initiation, and this initiation 
occurred overwhelmingly at adenine nucleotides (Watanabe et al. 2002). However, as 
the results showed, these insert fragments were too short, as none contained any 
upstream region sequences. Although during the Metaphor gel extraction of the nested 
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PCR, care was taken to only excise bands that were larger than the lengths of Exon 1 
and Exon 2 (based on primer binding site location) of these three genes; it is clear that 
some smaller bands were still present in the ligation reaction. Furthermore, in the 
ligation reaction these small inserts were then favoured. The reverse transcriptase 
reaction worked well, since the RNA control from the kit resulted in a band after 
running the cDNA in a PCR reaction with the appropriate kit primers. However, the 
Terminal deoxynucleotidyl transferase (TdT) tailing of the control first strand cDNA 
resulted in a faint band in the PCR control reaction, suggesting a low TdT tailing 
efficiency, and thus may have also affected the number of properly dc-tailed stevor 
cDNA transcripts as well. TdT tailing is used to add homopolymeric tails to the 3‟ 
ends of the cDNA. Finally the stability of the promoter region of P. falciparum genes, 
due to its high AT-rich content may also be a factor in the absence of any upstream 
region sequences seen in these clones. These may have degraded quite readily. Other 
cloning vectors have been recommended for cloning unstable DNA, especially AT-
rich DNA, for instance pSMART vectors made by Lucigen (USA). Using these 
vectors might be worth trying in subsequent 5‟RACE experiments with these genes 
(Godiska et al. 2004). 
 Following the difficulties encountered in these transfection experiments and 
5‟RACE experiment, several possibilities have arisen for future work to improve upon 
these problems. Once addressed, reliable and successful experiments may be possible, 
with results that will help in our understanding of this important P. falciparum multi-
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Table A Electroporation time constant (TC), voltage, Firefly LUs and Renilla LUs for 
each transfection using PF10_0395 NI FL and PF10_0395 NI FL V constructs 
  
 
Data for Figure 3.13 
PF10_0395 NI FL/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.2 307 4281 18666 0.23 
2 11.2 309 2654 14004 0.19 
PF10_0395 NI FL V/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.3 306 1458 17744 0.08 
2 10.1 307 2361 21584 0.11 
pPf86/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.8 336 37040 6736 5.50 
2 10.3 309 33879 4858 6.97 
Negative Control FL/Negative Control RL 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.2 309 72 552 0.13 
2 9.5 306 74 565 0.13 
 
 
Data for Figure 3.14 
PF10_0395 NI FL/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 11 309 3549 16872 0.21 
2 10.4 351 4176 23161 0.18 
PF10_0395 NI FL V/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.1 351 2315 23554 0.10 
2 11.4 309 2336 18366 0.13 
pPf86/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10 351 75215 12032 6.25 
2 10.1 351 92030 11461 8.03 
Negative Control FL/Negative Control RL 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 9.4 351 84 389 0.22 
















Data for Figure 3.15 – Re-invasion 
Before re-invasion 
PF10_0395 NI FL/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.4 306 4170 39846 0.06 
2 10.4 308 4791 48639 0.06 
PF10_0395 NI FL V/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 11.4 309 3136 52360 0.10 
2 10 351 2705 44559 0.10 
pPf86/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 9.6 307 91492 23002 3.98 
2 10 351 89274 21589 4.14 
Negative Control FL/Negative Control RL 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.1 306 67 327 0.20 
2 9.5 308 73 298 0.24 
After re-invasion 
PF10_0395 NI FL/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.4 306 1080 53341 0.02 
2 10.4 308 1066 58905 0.02 
PF10_0395 NI FL V/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 11.4 309 711 40851 0.02 
2 10 351 618 53760 0.01 
pPf86/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 9.6 307 27194 24451 1.11 
2 10 351 21932 25304 0.87 
Negative Control FL/Negative Control RL 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.1 306 138 465 0.30 
2 9.5 308 147 360 0.41 
 
 
Data for Figure 3.16 – Attempted repetition of re-invasion 
Before re-invasion 
PF10_0395 NI FL/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 12.2 336 1163 4427 0.26 
2 10 336 900 4363 0.21 
PF10_0395 NI FL V/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 12.6 336 553 3464 0.16 
2 12.4 336 424 2510 0.17 
pPf86/5’3’-UTR-actin-renilla luciferase 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 10.8 309 23389 3944 5.93 
2 10.6 309 23635 3084 7.58 
Negative Control FL/Negative Control RL 
 TC (ms) Pulse Voltage (V) Firefly LUs Renilla LUs Firefly/Renilla 
1 9.8 309 54 376 0.14 
2 9.4 351 71 303 0.23 
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Appendix B:  
 




Primer sequence  
 





PF10_0395_F1 5' – GGCAGATCTTCATGATATAAAATTCAATTTAATGTTTTG - 3' Forward 1930 58.45 
PF10_0395_F2 5' – GGCAGATCTAATGCACTATTTAAGAAAACCTCTCAA - 3' Forward 1730 59.27 
PF10_0395_F3 5' – GGCAGATCTCCCTTTAAATAAAACGAAATATGTATTATATT - 3' Forward 1441 57.85 
PF10_0395_R1_NI 5' –CCACCTAGGATAATGTGGTAATAATAAAGTATTAATTAAAAAGTTAAAC 
- 3' 
Reverse 69 58.62 
PF10_0395_R2_I 5' – CCACCTAGGATAATGTGGATTATGATTTTGGGTTT - 3' Reverse 286 58.77 
PFF0850C_F1 5' – GGCAGATCTACATATAATATCCAGTTATTAGAAATAATTGCA - 3' Forward 2003 58.8 
PFF0850C_F2 5' – GGCAGATCTATAACTTAAATATATTAGGTAAAATCTTAAAGTACCA - 3' Forward 1823 57.84 
PFF0850C_F3 5' – GGCAGATCTAAATATAATCTGAACAGATATTACGTTAATATACA - 3' Forward 1636 57.67 
PFF0850C_R1_NI 5' – CCACCTAGGATTATGGGATAATATTAATGTATTTACCAAAAA - 3' Reverse 69 58.97 
PFF0850C_R2_I 5' – CCACCTAGGTTCTTTGTTCAATTTGTCAATCATTT - 3' Reverse 326 58.87 
PFI0080w_F1 5' – GGCAGATCTATATATGGTCTCATGATATTAAATTAAATTTAAT - 3' Forward 2114 56.89 
PFI0080w_F2 5' – GGCAGATCTTACATGCTATTTATGAACACCTCGA - 3' Forward 1877 59.17 
PFI0080w_F3 5' – GGCAGATCTTTCTGTTACATTTTAATGTCATACGTAATATAAG - 3' Forward 1637 59.2 
PFI0080w_R1_NI 5' – CCACCTAGGATATTGTGGTAATACTAAAATATTTATCAAAAAGC - 3' Reverse 69 59.23 
PFI0080w_R2_I 5' – CCACCTAGGATAATGTGGATTATGGTTTTGTGTTT - 3' Reverse 282 57.74 
 
 
 
 
